[{"authors":["admin"],"categories":null,"content":"The various alleles of KRAS have known differences in their biochemical and signaling properties. Further, there are some correlations that suggest the allele has an effect on patient outcome.\nIn this analysis, we aim to compare the genetic landscapes of patient tumors with the common KRAS alleles.\n","date":1554595200,"expirydate":-62135596800,"kind":"taxonomy","lang":"en","lastmod":1554595200,"objectID":"2525497d367e79493fd32b198b28f040","permalink":"https://project-notebook-comutation.netlify.com/authors/admin/","publishdate":"0001-01-01T00:00:00Z","relpermalink":"/authors/admin/","section":"authors","summary":"The various alleles of KRAS have known differences in their biochemical and signaling properties. Further, there are some correlations that suggest the allele has an effect on patient outcome.\nIn this analysis, we aim to compare the genetic landscapes of patient tumors with the common KRAS alleles.","tags":null,"title":"Comutation of KRAS","type":"authors"},{"authors":null,"categories":null,"content":" Flexibility This feature can be used for publishing content such as:\n Online courses Project or software documentation Tutorials  The courses folder may be renamed. For example, we can rename it to docs for software/project documentation or tutorials for creating an online course.\nDelete tutorials To remove these pages, delete the courses folder and see below to delete the associated menu link.\nUpdate site menu After renaming or deleting the courses folder, you may wish to update any [[main]] menu links to it by editing your menu configuration at config/_default/menus.toml.\nFor example, if you delete this folder, you can remove the following from your menu configuration:\n[[main]] name = \u0026quot;Courses\u0026quot; url = \u0026quot;courses/\u0026quot; weight = 50  Or, if you are creating a software documentation site, you can rename the courses folder to docs and update the associated Courses menu configuration to:\n[[main]] name = \u0026quot;Docs\u0026quot; url = \u0026quot;docs/\u0026quot; weight = 50  Update the docs menu If you use the docs layout, note that the name of the menu in the front matter should be in the form [menu.X] where X is the folder name. Hence, if you rename the courses/example/ folder, you should also rename the menu definitions in the front matter of files within courses/example/ from [menu.example] to [menu.\u0026lt;NewFolderName\u0026gt;].\n","date":1536451200,"expirydate":-62135596800,"kind":"section","lang":"en","lastmod":1536451200,"objectID":"59c3ce8e202293146a8a934d37a4070b","permalink":"https://project-notebook-comutation.netlify.com/courses/example/","publishdate":"2018-09-09T00:00:00Z","relpermalink":"/courses/example/","section":"courses","summary":"Learn how to use Academic's docs layout for publishing online courses, software documentation, and tutorials.","tags":null,"title":"Overview","type":"docs"},{"authors":null,"categories":null,"content":" In this tutorial, I\u0026rsquo;ll share my top 10 tips for getting started with Academic:\nTip 1 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\nTip 2 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\n","date":1557010800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1557010800,"objectID":"74533bae41439377bd30f645c4677a27","permalink":"https://project-notebook-comutation.netlify.com/courses/example/example1/","publishdate":"2019-05-05T00:00:00+01:00","relpermalink":"/courses/example/example1/","section":"courses","summary":"In this tutorial, I\u0026rsquo;ll share my top 10 tips for getting started with Academic:\nTip 1 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim.","tags":null,"title":"Example Page 1","type":"docs"},{"authors":null,"categories":null,"content":" Here are some more tips for getting started with Academic:\nTip 3 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\nTip 4 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\n","date":1557010800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1557010800,"objectID":"1c2b5a11257c768c90d5050637d77d6a","permalink":"https://project-notebook-comutation.netlify.com/courses/example/example2/","publishdate":"2019-05-05T00:00:00+01:00","relpermalink":"/courses/example/example2/","section":"courses","summary":"Here are some more tips for getting started with Academic:\nTip 3 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus.","tags":null,"title":"Example Page 2","type":"docs"},{"authors":[],"categories":null,"content":" Click on the Slides button above to view the built-in slides feature.   Slides can be added in a few ways:\n Create slides using Academic\u0026rsquo;s Slides feature and link using slides parameter in the front matter of the talk file Upload an existing slide deck to static/ and link using url_slides parameter in the front matter of the talk file Embed your slides (e.g. Google Slides) or presentation video on this page using shortcodes.  Further talk details can easily be added to this page using Markdown and $\\rm \\LaTeX$ math code.\n","date":1906549200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1906549200,"objectID":"96344c08df50a1b693cc40432115cbe3","permalink":"https://project-notebook-comutation.netlify.com/talk/example/","publishdate":"2017-01-01T00:00:00Z","relpermalink":"/talk/example/","section":"talk","summary":"An example talk using Academic's Markdown slides feature.","tags":[],"title":"Example Talk","type":"talk"},{"authors":[],"categories":[],"content":" Add bootstrapped 95% CI to predicted KRAS allele frequency I added the bootstrapped 95% CI as error bars to the bar plots and as line ranges to the scatter plots. Here are the results for \u0026ldquo;any-hotspot\u0026rdquo; null hypothesis.\nPreparing additional PPI networks I added the steps for downloading all of the PPI networks to yesterday\u0026rsquo;s notebook.\nWhen trying to parse the IntAct data, it was very difficult to see a scalable method. I will talk to OP and see what she recommends and how she uses IntAct.\nI prepared both BioPlex2 and HINT PPI networks as tidygraph objects and cached them as bioplex_gr and hint_gr. Below are some summary statistics of the graphs (the data is stored in a cached data frame ppi_graph_summary_stats).\n   Metric STRING BioPlex2 HINT     num_edges 19354 10961 15674   num_vertices 725882 56553 179332   num_multiple 725882 0 26413   diameter 14 11 9   num_max_cliques 210988 46073 145594   mean_distance 3.79 4.28 3.47   transitivity 0.536 0.0605 0.0823    Analysis of PPI subnetworks from hits of comutation and dependency I began the deeper analysis of the PPI subnetworks by incorporating multiple subnetworks (as shown above). The number of data sources that support the presence of an interaction is shown by the weight of the edge in the network.\nI then used simulated annealing to identify clusters within the subnetworks. This likely most useful for very busy, \u0026ldquo;hairball\u0026rdquo; subnetworks, such as for LUAD G12C. Below is the full subnetwork for LUAD G12C that includes KRAS\nand the following are some of the extracted clusters.\n","date":1573776000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1573776000,"objectID":"0df4dba6b0624fe83e1f565a1c67d06c","permalink":"https://project-notebook-comutation.netlify.com/post/2019-11-15/","publishdate":"2019-11-15T00:00:00Z","relpermalink":"/post/2019-11-15/","section":"post","summary":"Add bootstrapped 95% CI to predicted KRAS allele frequency I added the bootstrapped 95% CI as error bars to the bar plots and as line ranges to the scatter plots. Here are the results for \u0026ldquo;any-hotspot\u0026rdquo; null hypothesis.\nPreparing additional PPI networks I added the steps for downloading all of the PPI networks to yesterday\u0026rsquo;s notebook.\nWhen trying to parse the IntAct data, it was very difficult to see a scalable method.","tags":[],"title":"2019-11-15","type":"post"},{"authors":[],"categories":[],"content":" Haigis Lab presentation I presented for the Haigis Lab meeting. The PowerPoint is in \u0026ldquo;presentations/\u0026rdquo;. I got some good feedback and added the recommendations to \u0026ldquo;TODO.md\u0026rdquo;.\nConfidence intervals for KRAS allele frequency I bootstrapped 95% CI for the predictions on the KRAS allele frequencies. The \u0026ldquo;Quick-R: Bootstrapping\u0026rdquo; article from DataCamp was a good resource for bootstrapping in R.\nThis analysis was added to \u0026ldquo;src/50_10_observed-predicted-kras-alleles.R\u0026rdquo;. The results are cached as kras_allele_freq_bootstrap_ci. TODO: I still need to add these values to the plots.\nAdditional PPI networks OP suggested that I use additional PPI networks along with STRING to increase the confidence of the reported interactions. With her help, I decided to use the following: - BioPlex 2.0 - IntAct - HINT - STRING\nThey were all downloaded to individual directories in \u0026ldquo;data/ppi-networks/\u0026rdquo;:\n# Move to directory for PPI networks. cd data/ppi-networks # Download BioPlex 2.0 network. curl https://bioplex.hms.harvard.edu/data/BioPlex_interactionList_v4a.tsv \\ -o bioplex2/bioplex2.txt \\ --insecure # Download IntAct network. cd intact curl -O ftp://ftp.ebi.ac.uk/pub/databases/intact/current/all.zip unzip all.zip cd ..  The HINT website id not provide a download URL nad I don\u0026rsquo;t care to discover their API for two simple downloads. I downloaded the \u0026ldquo;Binary\u0026rdquo; and \u0026ldquo;Co-complex\u0026rdquo; \u0026ldquo;High quality interactomes\u0026rdquo; for H. sapiens.\n","date":1573689600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1573689600,"objectID":"76f9d70f6e8adee87746e58c2e72ff08","permalink":"https://project-notebook-comutation.netlify.com/post/2019-11-14/","publishdate":"2019-11-14T00:00:00Z","relpermalink":"/post/2019-11-14/","section":"post","summary":"Haigis Lab presentation I presented for the Haigis Lab meeting. The PowerPoint is in \u0026ldquo;presentations/\u0026rdquo;. I got some good feedback and added the recommendations to \u0026ldquo;TODO.md\u0026rdquo;.\nConfidence intervals for KRAS allele frequency I bootstrapped 95% CI for the predictions on the KRAS allele frequencies. The \u0026ldquo;Quick-R: Bootstrapping\u0026rdquo; article from DataCamp was a good resource for bootstrapping in R.\nThis analysis was added to \u0026ldquo;src/50_10_observed-predicted-kras-alleles.R\u0026rdquo;. The results are cached as kras_allele_freq_bootstrap_ci.","tags":[],"title":"2019-11-14","type":"post"},{"authors":[],"categories":[],"content":" Preparation for lab meeting presentation Today, I just needed to make a few simple plots and augment some others for my lab meeting presentation.\nThe first was a plot of the distribution of KRAS alleles across the cancers. This was done in \u0026ldquo;src/90_05_kras-allele-distribution.R\u0026rdquo;\nThe next change was to make the overlap-network plots more \u0026ldquo;presentation-friendly\u0026rdquo; by adjusting the dimensions, color hues, and font size. I did not put an image here, because they are likely to be changed for the publication.\n","date":1573603200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1573603200,"objectID":"35d14143320b015a505d3796f34777a4","permalink":"https://project-notebook-comutation.netlify.com/post/2019-11-13/","publishdate":"2019-11-13T00:00:00Z","relpermalink":"/post/2019-11-13/","section":"post","summary":"Preparation for lab meeting presentation Today, I just needed to make a few simple plots and augment some others for my lab meeting presentation.\nThe first was a plot of the distribution of KRAS alleles across the cancers. This was done in \u0026ldquo;src/90_05_kras-allele-distribution.R\u0026rdquo;\nThe next change was to make the overlap-network plots more \u0026ldquo;presentation-friendly\u0026rdquo; by adjusting the dimensions, color hues, and font size. I did not put an image here, because they are likely to be changed for the publication.","tags":[],"title":"2019-11-13","type":"post"},{"authors":[],"categories":[],"content":" Fix observed vs predicted KRAS allele frequency plots I separated each cancer into its own plot and also provided a copy showing the statistical significance in the shape and size of the point. I fixed yesterday\u0026rsquo;s notebook to reflect these changes.\nI also removed the KRAS mutations themselves from factoring into the prediction, but the change had little effect on any of the predictions.\nMinor fixes to other plots I addressed the minor styling changes to the plots mentioned in yesterday notebook:\n To waterfall plots in \u0026ldquo;90_03_mutation-burden-distribution\u0026rdquo;: make shorter and wider \u0026ldquo;20_35_rc-fisher-comparison/rc_mutations_distribition.svg\u0026rdquo;: let each axis scale separately.  Table of mutation rates of all genes I added a section to \u0026ldquo;src/20_50_rainfall-plots.R\u0026rdquo; to make a table of rates of comutation with each allele, with mutant KRAS, with WT, and overall.\n","date":1573516800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1573516800,"objectID":"3bb4cb58d411c533b943abe567a4ae7e","permalink":"https://project-notebook-comutation.netlify.com/post/2019-11-12/","publishdate":"2019-11-12T00:00:00Z","relpermalink":"/post/2019-11-12/","section":"post","summary":"Fix observed vs predicted KRAS allele frequency plots I separated each cancer into its own plot and also provided a copy showing the statistical significance in the shape and size of the point. I fixed yesterday\u0026rsquo;s notebook to reflect these changes.\nI also removed the KRAS mutations themselves from factoring into the prediction, but the change had little effect on any of the predictions.\nMinor fixes to other plots I addressed the minor styling changes to the plots mentioned in yesterday notebook:","tags":[],"title":"2019-11-12","type":"post"},{"authors":[],"categories":[],"content":" Refine rainfall plots I first had to fix a mistake in the creation of the MAF-compliant tibble by removing hypermutants. This had no effects on the results because the hypermutants were removed from the initial tests for comutation and mutual exclusivity. The only effect was to make some comutation interactions look even more striking.\nThe second fix was to set some custom sizes for the manually-selected plots. This was purely aesthetic.\nColoration of synthetic lethal heat maps I updated the color scale used for the heatmaps to use the orange and purple for up and down effects, respectively:\nThis was pretty simple to do, and for future reference, here was all I had to do.\npal \u0026lt;- c(synthetic_lethal_pal[\u0026quot;down\u0026quot;], \u0026quot;grey95\u0026quot;, synthetic_lethal_pal[\u0026quot;up\u0026quot;]) pal \u0026lt;- colorRampPalette(pal)(7) ph \u0026lt;- pheatmap::pheatmap( mod_data, color = pal, ... )  Fix observed vs. predicted allele frequency plots Originally, GM used some funky formulation to create the observed vs. predicted plots was way to convoluted - he wasn\u0026rsquo;t even able to explain it to me in person, so how could I do it in text? Therefore, I wanted to create a simpler formulation to answer the question: If a sample was to have a KRAS mutation, what is the most likely one for it to get if decided by mutational signatures?\nMy formulation is as follows:\n for a tumor sample:  for each trinucleotide mutation $m$ with context $c$ that can cause a KRAS mutation:  calculate: $\\frac{|m|}{|c|}$  for each allele $a$:  $p(a) = \\sum{p(m)} \\quad \\text{where} \\quad m \\rightarrow a$  normalize such that ${A} \\Rightarrow \\sum^{A}{a} = 1$   This approach assumes that all codons are the same. If we were interested in only G12 mutations (the null hypothesis being that all G12 mutations are equal), then the same approach is followed again, but only normalizing the G12 mutations at the end.\nThe data I used was from GM:\n \u0026rdquo;/n/data1/hms/dbmi/park/gmelloni/cooc_mutex_driver/data/cbioportal/\u0026rdquo;:  \u0026ldquo;paad_luad_coadread_skcm_mm_tricLong_newAug2019.rds\u0026rdquo; \u0026ldquo;context_and_signa_paad_luad_coadread_skcm_mm_NEW.rds\u0026rdquo;   It was prepared in \u0026ldquo;munge/50_trinucleotide-mutations.R\u0026rdquo;\nThe analysis was conducted in \u0026ldquo;src/50_10_observed-predicted-kras-alleles.R\u0026rdquo;. The box plot below shows the distribution of predicted allele frequencies in each cancer.\nThe bar plot shows the same data, just taking the average across all samples. The error bars indicate the SEM.\nThe following bar plot, again, shows the same results, just stratified by allele across cancers.\nBelow are the results for two different null hypothesis: 1) all KRAS hotspots are equivalent, and 2) all KRAS G12 alleles are equivalent.\nCOAD LUAD MM PAAD I ran a binomial test to find which observed rates of the alleles matched the predicted. The alleles that could be predicted (p \u0026gt; 0.05) trinucleotide context are shown below.\n   Cancer Allele Obs. allele freq. Pred. allele freq p-value     COAD G12A 0.0371 0.0314 0.445   COAD G12R 0.00977 0.0171 0.301   COAD Q61L 0.00977 0.0133 0.697   LUAD Q61L 0.0141 0.0249 0.503   MM G12A 0.0604 0.0431 0.171   MM G12C 0.0302 0.0332 1   MM G12D 0.121 0.0910 0.108   MM G12V 0.0717 0.0602 0.436   MM G13D 0.128 0.104 0.191   MM Q61R 0.0528 0.0453 0.552    The alleles that could be predicted (p \u0026gt; 0.05) when only considering the G12 alleles are show below.\n   Cancer Allele Obs. allele freq. Pred. allele freq p-value     COAD G12D 0.293 0.321 0.185   COAD G12V 0.195 0.196 1   LUAD G12A 0.0892 0.0717 0.350   LUAD G12D 0.122 0.139 0.552   LUAD G12V 0.225 0.253 0.386   MM G12R 0.0528 0.0621 0.612    Minor changes to make:\n To waterfall plots in \u0026ldquo;90_03_mutation-burden-distribution\u0026rdquo;: make shorter and wider \u0026ldquo;20_35_rc-fisher-comparison/rc_mutations_distribition.svg\u0026rdquo;: let each axis scale separately.  ","date":1573430400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1573430400,"objectID":"ea18cbbe88831e8140327e2c82d2d337","permalink":"https://project-notebook-comutation.netlify.com/post/2019-11-11/","publishdate":"2019-11-11T00:00:00Z","relpermalink":"/post/2019-11-11/","section":"post","summary":"Refine rainfall plots I first had to fix a mistake in the creation of the MAF-compliant tibble by removing hypermutants. This had no effects on the results because the hypermutants were removed from the initial tests for comutation and mutual exclusivity. The only effect was to make some comutation interactions look even more striking.\nThe second fix was to set some custom sizes for the manually-selected plots. This was purely aesthetic.","tags":[],"title":"2019-11-11","type":"post"},{"authors":[],"categories":[],"content":" Touch-ups and preparations for figures-quality images I spent today taking casre of some smaller, but necessary, adjustments to previously created figures in order to prepare them for use a figure.\nStandardizing color palettes for comutation and synthetic lethality I want a pair of colors for comutation vs. mutual exclusivity and another pair for synthetic lethal up and down.\nWhile I was at it, I made my own palette-display function. Below are the rest of the palettes used throughout the paper.\nMake more tightly packed high-level genetic interaction networks Since the purpose of the high-level genetic interaction networks is to show thee relations between the alleles, it need not take up too much space. I made small figures that will still relay our point, but not take up half the figure. These replace the \u0026ldquo;thick\u0026rdquo; versions.\nCOAD LUAD MM PAAD Finalize distribution of interactions plot I just tidied up this plot that was originally just for my own use.\nTo-Do tomorrow What I should do tomorrow:\n Update the heatmap for synthetic lethality to use the new color palette. Finally fix the observed vs. predicted KRAS alleles.  ","date":1573257600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1573257600,"objectID":"c594216cc75310f08e4e04b10f11edcc","permalink":"https://project-notebook-comutation.netlify.com/post/2019-11-09/","publishdate":"2019-11-09T00:00:00Z","relpermalink":"/post/2019-11-09/","section":"post","summary":"Touch-ups and preparations for figures-quality images I spent today taking casre of some smaller, but necessary, adjustments to previously created figures in order to prepare them for use a figure.\nStandardizing color palettes for comutation and synthetic lethality I want a pair of colors for comutation vs. mutual exclusivity and another pair for synthetic lethal up and down.\nWhile I was at it, I made my own palette-display function. Below are the rest of the palettes used throughout the paper.","tags":[],"title":"2019-11-09","type":"post"},{"authors":[],"categories":[],"content":" Correlating mutation frequency and number of genetic interactors I created a scatter plot of the frequency of the KRAS allele against the number of genetic interactors (comutation or mutual exclusivity). This analysis was added to the end of \u0026ldquo;src/20_40_highlivel-genetic-interactions.R\u0026rdquo;\nSome minor changes I took care of a few small changes to various parts of the analysis:\nI fixed some typos in to the mapping_mutation_types_to_human_readable. I had to re-run \u0026ldquo;munge/20_prepare-cancer-data.R\u0026rdquo; and \u0026ldquo;src/90_03_mutation-burden-distribution.R\u0026rdquo; to update data tables and figures.\nI ran functional enrichment on the synthetic lethal hits without separating by cluster. These results will be referenced in the text, included as a supplementary table, and (maybe) a supplementary figure. This analysis was tacked onto the end of \u0026ldquo;src/10_13_linear-modeling-syn-let_fxnal-enrichment.R\u0026rdquo; The TSVs of the results are available in \u0026ldquo;tables/10_10_linear-modeling-syn-let\u0026rdquo; and the plots are in \u0026ldquo;graphs/10_13_linear-modeling-syn-let_fxnal-enrichment\u0026rdquo; with the \u0026ldquo;overall.svg\u0026rdquo; suffix.\nComparison of synthetic lethal hits and comutation interactions I first needed to solidify the clusters for the heatmaps of the synthetic lethal hits. I tried a bunch of clustering and distance methods for the creation of the clusters and found the \u0026ldquo;manhattan\u0026rdquo; distance method with the \u0026ldquo;ward.D2\u0026rdquo; clustering method to work the best.\nWith the clusters established, I had to re-run all of the downstream analyses. This will break some images earlier in the notebook. (I will also need to go and fix the Project page for the synthetic lethal analysis.)\nThis first analysis was done in \u0026ldquo;src/40_10_overlap-synlet-comutation.R\u0026rdquo;.\nI originally tried to bin the genes into manually-defined clusters based on visual interpretation of the heatmaps, but this lacked nuance, was not scalable, was too fragile, etc. Instead, I calculated the pairwise t-tests between all alleles for each gene that passed the ANOVA. These results were filtered at a FDR-adjusted p-value \u0026lt; 0.10.\nThe first round of plots were created and some are copied below - I have yet to pick through them and decide which to investigate further. The shape indicates in which genetic test the interaction was found. The color indicates a detail about the genetic interaction in the context of the test; for genetic interactions, the color indicates comutation or mutual exclusivity, while for synthetic lethality, the color indicates the direction in which the depletion effect is different from the average of the rest.\nSome information that is missing but would be interesting to try to include if it doesn\u0026rsquo;t get too cluttered would be more specifics on which comparison was significantly different for the synthetic lethal interaction. Perhaps, I can include the box-plots for a few of the genes and manually draw a line to the respective node.\nI also want to include some sort of comparisons amongst the plots, especially between the subnetworks that contain KRAS.\nSOME EXAMPLES\nCOAD G12D COAD G13D LUAD G12V LUAD WT PAAD G12D PAAD G12R PAAD G12V ","date":1573171200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1573171200,"objectID":"01bef31d8f49f185bf7efe1e1ef193a5","permalink":"https://project-notebook-comutation.netlify.com/post/2019-11-08/","publishdate":"2019-11-08T00:00:00Z","relpermalink":"/post/2019-11-08/","section":"post","summary":"Correlating mutation frequency and number of genetic interactors I created a scatter plot of the frequency of the KRAS allele against the number of genetic interactors (comutation or mutual exclusivity). This analysis was added to the end of \u0026ldquo;src/20_40_highlivel-genetic-interactions.R\u0026rdquo;\nSome minor changes I took care of a few small changes to various parts of the analysis:\nI fixed some typos in to the mapping_mutation_types_to_human_readable. I had to re-run \u0026ldquo;munge/20_prepare-cancer-data.R\u0026rdquo; and \u0026ldquo;src/90_03_mutation-burden-distribution.","tags":[],"title":"2019-11-08","type":"post"},{"authors":[],"categories":[],"content":" Oncoplots I completed making oncogenes for hand-selected genes. The goal was to focus attention on interactions with notable genes or especially striking interactions. (These plots are available in \u0026ldquo;graphs/20_50_rainfall-plots-select/\u0026ldquo;.)\nCOAD A striking plot is of the comutation interactions with A146T in COAD.\nThe plot for G12D mutually exclusive interactions in COAD was impressive.\nLUAD The plot for G12D in LUAD, though, shows a definite reduction in the rate of comutation with TP53.\nPAAD Another interesting comutation event is found in PAAD between G12R and RAF1 and IRAK1. While the mutations are rare, in general, there is a definite enrichment for tumors with G12R.\nOverall, there were a substantial number of interactions with RYR genes. In PAAD, RYR3 comutates with G12V and RYR1 is mutually exclusive with G12V.\nSome of the most interesting and striking results were from the PAAD Q61H plots. Below are some of the mutually exclusive interactions.\nThe plot below shows the strong comutation interaction with TP53.\nI then made oncoplots of the genes in the a priori gene lists. These accompany the genetic subnetworks from the a priori gene sets. (These plots are available in \u0026ldquo;graphs/20_50_rainfall-plots-apriori/\u0026ldquo;.) They don\u0026rsquo;t generally show anything different than in the above selection.\nDistribution of mutations per sample across cancers We will want to include the distribution of mutational burden in our tumor samples as a supplemental figure for the paper. These plots were made in \u0026ldquo;src/90_03_mutation-burden-distribution.R\u0026rdquo; and were saved to \u0026ldquo;graphs/90_03_mutation-burden-distribution/\u0026ldquo;. For each plot shown below, the top is of all mutations and bottom is of coding mutations. For COAD, the hypermutants have an \u0026ldquo;x\u0026rdquo; shape.\nI also made plots showing the distribution of the types of mutation found in each samples from each data source.\n(I had to return to the munging of the mutation data from GM to standardize the types of mutation in the mutation_type column - I created a new column mutation_type_hr where \u0026ldquo;hr\u0026rdquo; stands for \u0026ldquo;human-readable\u0026rdquo;.)\n","date":1573084800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1573084800,"objectID":"db527c50d14d52b0f77fd8d9db11c984","permalink":"https://project-notebook-comutation.netlify.com/post/2019-11-07/","publishdate":"2019-11-07T00:00:00Z","relpermalink":"/post/2019-11-07/","section":"post","summary":"Oncoplots I completed making oncogenes for hand-selected genes. The goal was to focus attention on interactions with notable genes or especially striking interactions. (These plots are available in \u0026ldquo;graphs/20_50_rainfall-plots-select/\u0026ldquo;.)\nCOAD A striking plot is of the comutation interactions with A146T in COAD.\nThe plot for G12D mutually exclusive interactions in COAD was impressive.\nLUAD The plot for G12D in LUAD, though, shows a definite reduction in the rate of comutation with TP53.","tags":[],"title":"2019-11-07","type":"post"},{"authors":[],"categories":[],"content":" Fix GSEA The problem I ran into yesterday was that there are some enriched gene sets that do not have enrichment plots (\u0026ldquo;enplot\u0026rdquo;). I guess that\u0026rsquo;s just how GSEA does it.\nWhile figuring this out, though, I saw that GSSEA thought there were 18 COAD G12V samples and 3 \u0026ldquo;other\u0026rdquo; - this is backwards. After some careful inspection, I was able to confirm the relationship between the depletion effect in DepMap and NES from GSEA:\n stronger to weaker depletion = positive to negative NES\n Update synthetic lethal project page I finished updating the project page for the synthetic lethal portion of the paper.\nUpdate comutation project page I updated the comutation project page with a few new figures. Namely, I added the dot-plot that shows the distribution of the mutually exclusive events for the cancers and the related oncoplots.\nTo-do tomorrow\nContinue selecting the genes to show for the more selective oncoplots. ALso, I need to make them for the genetic interaction network of the a priori lists.\nI have some notes in my notebook I took while at the GRIP talks that need to be transcribed to the \u0026ldquo;TODO.md\u0026rdquo; file.\n","date":1572998400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1572998400,"objectID":"7fd064130a347efa44a3e165e7882d5e","permalink":"https://project-notebook-comutation.netlify.com/post/2019-11-06/","publishdate":"2019-11-06T00:00:00Z","relpermalink":"/post/2019-11-06/","section":"post","summary":"Fix GSEA The problem I ran into yesterday was that there are some enriched gene sets that do not have enrichment plots (\u0026ldquo;enplot\u0026rdquo;). I guess that\u0026rsquo;s just how GSEA does it.\nWhile figuring this out, though, I saw that GSSEA thought there were 18 COAD G12V samples and 3 \u0026ldquo;other\u0026rdquo; - this is backwards. After some careful inspection, I was able to confirm the relationship between the depletion effect in DepMap and NES from GSEA:","tags":[],"title":"2019-11-06","type":"post"},{"authors":[],"categories":[],"content":" RANi-screen Analysis I conducted the same analysis as was previously done on the CRISPR screen. Therefore, the analysis was added to \u0026ldquo;src/10_10_linear-modeling-syn-let.R\u0026rdquo;.\nThe data was first prepared in \u0026ldquo;munge/15_depmap19Q3_model-data-prep.R\u0026rdquo;. All missing data was removed. There are a lot more cell lines per allele.\n   cancer allele n     COAD G12V 4   COAD G13D 5   COAD G12D 7   COAD WT 13   LUAD G12V 6   LUAD G12C 13   LUAD WT 54   PAAD G12R 4   PAAD G12V 8   PAAD G12D 18    The results are rather unimpressive. To begin, there is a lot of missing data! I looked on DepMaps website and data portal but couldn\u0026rsquo;t find an explanation. Also, there were not very many striking differences between the alleles. The heatmaps for each cancer are below.\nCOAD LUAD PAAD Conclusion It does not seem like these results are worth further investigating.\nI spent the rest of the day working on summarizing the current status of the DepMap analysis. I did find a bug on the parsing of the GSEA results that I still have yet to resolve. There is a browser() call in \u0026ldquo;src/10_37_gsea-depmap-analysis.R\u0026rdquo;.\n","date":1572912000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1572912000,"objectID":"af4b6eb08aaed39e5a9eec26bb2ab02f","permalink":"https://project-notebook-comutation.netlify.com/post/2019-11-05/","publishdate":"2019-11-05T00:00:00Z","relpermalink":"/post/2019-11-05/","section":"post","summary":"RANi-screen Analysis I conducted the same analysis as was previously done on the CRISPR screen. Therefore, the analysis was added to \u0026ldquo;src/10_10_linear-modeling-syn-let.R\u0026rdquo;.\nThe data was first prepared in \u0026ldquo;munge/15_depmap19Q3_model-data-prep.R\u0026rdquo;. All missing data was removed. There are a lot more cell lines per allele.\n   cancer allele n     COAD G12V 4   COAD G13D 5   COAD G12D 7   COAD WT 13   LUAD G12V 6   LUAD G12C 13   LUAD WT 54   PAAD G12R 4   PAAD G12V 8   PAAD G12D 18    The results are rather unimpressive.","tags":[],"title":"2019-11-05","type":"post"},{"authors":[],"categories":[],"content":" More attempts at modeling DepMap data I did some reading and thinking in the morning and came up with a few more linear modeling analyses I wanted to try:\n z(gene_effect) ~ allele  This is essentially what I have already done, but with z-scaled gene-effect scores.  A rank-sum test for each sample looking for enrichment of genes in a priori gene sets. I should z-scale the gene-effect scores within a gene first and then conduct the rank-sum within a sample.  Scaled gene effect for ANOVA I conducted the simple ANOVA test using the z-scaled gene effect scores. The pairwise test was also conducted on the scaled values. The results were identical - no new genes, no lost genes. The ANOVA test was reverted to the unscaled form.\nRank-sum test for single-sample enrichment I ran a rank-sum test for each cell line, where the genes were ranked by the z-scaled gene-effect score. The two groups were created by gene-sets, therefore, the test was a sample-wise gene-set enrichment test. I used the KEGG and KEA gene sets. These results were not very conclusive because it was difficult to make statements on the allele by the effects of a cell line.\nTherefore, I also ran the same test by allele instead of by cell line. I used the mean of the gene-effect for the cell lines of an allele and then z-scaled. Some of the results are shown below.\nThe first plot is a general overview of the enriched pathways. Each dot represents a statistically detectable enrichment and the size of the dot correlates with the FDR-adjusted p-value.\nThe following are waterfall plots that show the scaled average gene-effect score for cell lines of a KRAS allele for the genes in an enriched gene set. The x-axis order is by ranking of the y-axis.\nCOAD LUAD PAAD RANi-screen Analysis (To-Do) Compare correlations between RNAi and CRISPR results. \u0026ldquo;Integrative\u0026rdquo; analysis with both data sources.\n","date":1572825600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1572825600,"objectID":"01114a368d6040a9b80df4369f208b4e","permalink":"https://project-notebook-comutation.netlify.com/post/2019-11-04/","publishdate":"2019-11-04T00:00:00Z","relpermalink":"/post/2019-11-04/","section":"post","summary":"More attempts at modeling DepMap data I did some reading and thinking in the morning and came up with a few more linear modeling analyses I wanted to try:\n z(gene_effect) ~ allele  This is essentially what I have already done, but with z-scaled gene-effect scores.  A rank-sum test for each sample looking for enrichment of genes in a priori gene sets. I should z-scale the gene-effect scores within a gene first and then conduct the rank-sum within a sample.","tags":[],"title":"2019-11-04","type":"post"},{"authors":[],"categories":[],"content":" Therapeutically-viable synthetic lethal hits Instead of trying to define specific thresholds for defining the therapeutically-viable synthetic lethal hits, there were so few hits, that I can look manually and pull out some of the more interesting ones.\nI used the results of the functional enrichment to guide my choices. Below are the results of looking for functional enrichment in the clusters from the synthetic lethal analysis. I used a threshold of FDR-adjusted p-value \u0026lt; 0.20 and at least 3 genes in the group to filter the results. There was no enrichment in COAD.\nCOAD LUAD PAAD Essential or Nonessential genes? I was curious if any of the genes found to have differential dependency scores across the KRAS alleles were listed as pan-essential or pan-nonessential by DepMap. To my surprise, quite a few were. I could not think of anything to do with the information, so I wrote it to file (\u0026ldquo;tables/10_17_linear-modeling-syn-let_specific-protein-types/essential-genes-with-allele-specific-dep.tsv\u0026rdquo;) and also copied it here.\n   cancer hugo_symbol gene cluster entrez_id label     COAD CDC37 1 11140 essential   COAD EIF3M 2 10480 essential   COAD FDPS 1 2224 essential   COAD HYPK 2 25764 essential   COAD MRPL47 3 57129 essential   COAD NDUFS5 3 4725 essential   COAD REV3L 2 5980 essential   COAD ROMO1 1 140823 essential   COAD RPL36AL 2 6166 essential   COAD RPRD1B 3 58490 essential   COAD WDR26 2 80232 essential   LUAD ARMC6 2 93436 essential   LUAD ATP6V1F 4 9296 essential   LUAD BNIP1 2 662 essential   LUAD COPB1 3 1315 essential   LUAD DHFR 1 1719 essential   LUAD GPN2 3 54707 essential   LUAD HNRNPA0 2 10949 essential   LUAD HNRNPU 2 3192 essential   LUAD IK 1 3550 essential   LUAD INTS13 4 55726 essential   LUAD IWS1 3 55677 essential   LUAD LURAP1 2 541468 essential   LUAD NAGLU 2 4669 essential   LUAD NMT1 2 4836 essential   LUAD NOL8 1 55035 essential   LUAD NPM3 4 10360 essential   LUAD PCF11 3 51585 essential   LUAD PDCD6 2 10016 essential   LUAD PNISR 3 25957 essential   LUAD PTK2 3 5747 essential   LUAD RAB4A 1 5867 essential   LUAD RBM25 3 58517 essential   LUAD RMI1 4 80010 essential   LUAD RPL27A 2 6157 essential   LUAD RPL4 1 6124 essential   LUAD RPS13 1 6207 essential   LUAD RPS3 1 6188 essential   LUAD SF3A3 1 10946 essential   LUAD SF3B1 4 23451 essential   LUAD SMN2 2 6607 essential   LUAD SNRNP35 2 11066 essential   LUAD SRRM2 3 23524 essential   LUAD SUGT1 4 10910 essential   LUAD TAF1B 2 9014 essential   LUAD TSG101 2 7251 essential   LUAD U2SURP 3 23350 essential   LUAD UBA3 2 9039 essential   LUAD UBC 2 7316 essential   LUAD UQCRQ 2 27089 essential   LUAD WDR74 2 54663 essential   LUAD ZNF720 3 124411 essential   LUAD ZNF763 3 284390 essential   PAAD CCT8 2 10694 essential   PAAD COX15 3 1355 essential   PAAD CWF19L2 3 143884 essential   PAAD EGLN2 4 112398 essential   PAAD EXOSC2 1 23404 essential   PAAD HSPE1 4 3336 essential   PAAD METTL3 2 56339 essential   PAAD MRPL24 3 79590 essential   PAAD MRPS25 3 64432 essential   PAAD RPL4 1 6124 essential   PAAD RPL7L1 3 285855 essential   PAAD RPS3 3 6188 essential   PAAD SNAPC2 4 6618 essential   PAAD SNAPC5 1 10302 essential   PAAD TMED2 1 10959 essential   PAAD TUBA1C 3 84790 essential   PAAD U2AF1 4 7307 essential   PAAD UPF2 1 26019 essential    ","date":1572739200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1572739200,"objectID":"b1abaeaac8c1dcbb8d1cfaf713ce2ded","permalink":"https://project-notebook-comutation.netlify.com/post/2019-11-03/","publishdate":"2019-11-03T00:00:00Z","relpermalink":"/post/2019-11-03/","section":"post","summary":"Therapeutically-viable synthetic lethal hits Instead of trying to define specific thresholds for defining the therapeutically-viable synthetic lethal hits, there were so few hits, that I can look manually and pull out some of the more interesting ones.\nI used the results of the functional enrichment to guide my choices. Below are the results of looking for functional enrichment in the clusters from the synthetic lethal analysis. I used a threshold of FDR-adjusted p-value \u0026lt; 0.","tags":[],"title":"2019-11-03","type":"post"},{"authors":[],"categories":[],"content":" Fix modeling of the synthetic lethality Fixing data issues The first thing to fix was to remove the EGFR-mutant samples from the KRAS WT. Just like with BRAF and NRAS, though, I only removed cell lines with known activating mutations.\nI took this as a good time to fix an issue with duplicated data. The problem came from rows of the dependency table being copied during joins to other data frames. I went through the munging scripts and found the few places where this was happening, fixing this issue. (I also fixed some mistakes with gene name parsing.)\nI removed all of the cached data and reloaded the project to build everything from scratch.\nI reran the modeling and recreated the heatmaps and box-plots.\nNext steps Below are the following next steps for this portion of the paper.\n Conduct a similar analysis with the RNAi screen data.  Any overlapping genes should be highlighted in the paper.  Functional enrichment of the clusters. See if there is any overlap with the comutation and mutually exclusive interactors. Identify and highlight any \u0026ldquo;therapeutically viable\u0026rdquo; targets in the hits. Are any of the hits considered \u0026ldquo;pan-essential\u0026rdquo; or \u0026ldquo;pan-nonessential\u0026rdquo; by DepMap? See if any of the hits in the a priori genes of interest.  ","date":1572652800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1572652800,"objectID":"f0392c960e49ee62fd89f8b0fc9f335c","permalink":"https://project-notebook-comutation.netlify.com/post/2019-11-02/","publishdate":"2019-11-02T00:00:00Z","relpermalink":"/post/2019-11-02/","section":"post","summary":"Fix modeling of the synthetic lethality Fixing data issues The first thing to fix was to remove the EGFR-mutant samples from the KRAS WT. Just like with BRAF and NRAS, though, I only removed cell lines with known activating mutations.\nI took this as a good time to fix an issue with duplicated data. The problem came from rows of the dependency table being copied during joins to other data frames.","tags":[],"title":"2019-11-02","type":"post"},{"authors":[],"categories":[],"content":" Descriptive plots for cell lines used by DepMap (cont.) I improved the mutation tile plots from yesterday by adding bar-plots for the margins. The images are available in yesterday\u0026rsquo;s notebook.\nOverall dependencies of the cell lines by KRAS allele GM had a good suggesting of looking at the overall distribution of dependencies of the cell lines by KRAS allele. Perhaps, the \u0026ldquo;stronger\u0026rdquo; alleles will have reduced dependencies overall.\nThe analysis was done in \u0026ldquo;src/10_45_overall-dependencies-by-allele.R\u0026rdquo;\nI made two plots for each cancer and see nothing from either of them. The left plot shows the distribution of dependencies for the alleles (each gene\u0026rsquo;s score was averaged across the represented cell lines.) The right plot shows the quantile values for the gene scores of each allele.\n(I also tried scaling the gene scores across all cell lines before average within each allele, but found nothing interesting, still.)\nSpecify therapeutically viable genes from synthetic lethal hits The heatmaps showing the allele-specific dependencies show any gene with a detectable difference across the alleles. I want to specify which hits are \u0026ldquo;therapeutically viable\u0026rdquo;. To qualify for this, the gene was be lethal in one context, but not in another. Therefore, of the hits, I applied the following filters:\n in at least one, but not all, alleles, the average effect was stronger than the cut-off derived from the non-essential and essential genes the difference is statistically significant  This analysis was done in \u0026ldquo;src/10_16_linear-modeling-syn-let_therapeutics.R\u0026rdquo;\nDuring the analysis, I noticed that some data from cell lines was repeated. I looked back and found that that was used for the original analysis. I have gone back to \u0026ldquo;src/10_10_linear-modeling-syn-let.R\u0026rdquo; and fixed the problem. TODO: I still need to fix one bug in plotting of the results from the fixed analysis.\nNotes on observed vs. predicted KRAS allele frequency In \u0026ldquo;Assessment of mutation probabilities of KRAS G12 missense mutants and their long-timescale dynamics by atomistic molecular simulations and Markov state modeling\u0026rdquo; Pantsar et al. (2018, PMID: 30199525) conducted an analysis of the frequency of KRAS alleles in different cancers, measuring the extent to which the alleles were distributed at random. They found that the alleles could not be explained by random chance, especially G12R in PAAD. Below is their abstract:\n A mutated KRAS protein is frequently observed in human cancers. Traditionally, the oncogenic properties of KRAS missense mutants at position 12 (G12X) have been considered as equal. Here, by assessing the probabilities of occurrence of all KRAS G12X mutations and KRAS dynamics we show that this assumption does not hold true. Instead, our findings revealed an outstanding mutational bias. We conducted a thorough mutational analysis of KRAS G12X mutations and assessed to what extent the observed mutation frequencies follow a random distribution. Unique tissue-specific frequencies are displayed with specific mutations, especially with G12R, which cannot be explained by random probabilities. To clarify the underlying causes for the nonrandom probabilities, we conducted extensive atomistic molecular dynamics simulations (170 s) to study the differences of G12X mutations on a molecular level. The simulations revealed an allosteric hydrophobic signaling network in KRAS, and that protein dynamics is altered among the G12X mutants and as such differs from the wild-type and is mutation-specific. The shift in long-timescale conformational dynamics was confirmed with Markov state modeling. A G12X mutation was found to modify KRAS dynamics in an allosteric way, which is especially manifested in the switch regions that are responsible for the effector protein binding. The findings provide a basis to understand better the oncogenic properties of KRAS G12X mutants and the consequences of the observed nonrandom frequencies of specific G12X mutations.\n Below is an excerpt from the analysis of mutation frequencies. They used the ratio of transition to transversions to create their null distribution.\n We evaluated how random the occurrences of the specific G12X mutations are. To this end, we used the transition:transversion mutation ratio as a figure of merit, and compared this figure to a value of 2.3, which is the ratio for missense mutations observed in large-scale genomic analyses (34,35). If the mutations would take place randomly, G12D and G12S mutations should be the most abundant mutations as they are transition mutations (S2 Fig). G12D mutation is consistent with this view, as it occurs very often in all tissues. Meanwhile, G12S is not consistent with this behavior at all, as it occurs in tumors, perhaps surprisingly, very rarely. Also, regardless of the tissue type, the G12V mutation is over-expressed compared to values expected based on the assumption of random occurrences. Concluding, the mutations probabilities of occurrences are not consistent with a transition:transversion mutation ratio based on a random process.\n Supp. Fig. 2\nNew metric We want to plot observed vs. predicted frequency of the KRAS mutations; we need a new metric for predicted. The null is that the KRAS allele that each individual has was decided at random - the choice of KRAS allele was random and any would suffice. I need to figure out some measurement that calculates the predicted frequency of each allele given this null.\nNotes from meeting with KH  remove EGFR-activated mutants from KRAS WT in DepMap.  Comments from Jake about oncoplots  Overall, he was very positive about them. Look more closely at the overlap of the other genes found to comutate/mut. ex. with a KRAS allele and see if any of them lie in the same pathways. Limit the number of rows shown to just those with obviously striking results.  ","date":1572566400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1572566400,"objectID":"f4e8fa197309f91d3432e65f0265fbac","permalink":"https://project-notebook-comutation.netlify.com/post/2019-11-01/","publishdate":"2019-11-01T00:00:00Z","relpermalink":"/post/2019-11-01/","section":"post","summary":"Descriptive plots for cell lines used by DepMap (cont.) I improved the mutation tile plots from yesterday by adding bar-plots for the margins. The images are available in yesterday\u0026rsquo;s notebook.\nOverall dependencies of the cell lines by KRAS allele GM had a good suggesting of looking at the overall distribution of dependencies of the cell lines by KRAS allele. Perhaps, the \u0026ldquo;stronger\u0026rdquo; alleles will have reduced dependencies overall.\nThe analysis was done in \u0026ldquo;src/10_45_overall-dependencies-by-allele.","tags":[],"title":"2019-11-01","type":"post"},{"authors":[],"categories":[],"content":" Notes from Haigis Lab Retreat 2019 Below are just a few scattered notes from the Haigis Lab Retreat 2019:\n Channing Der just published on G12R declaring it relies on a KRAS-independent macropinocyctosis pathway available in the pancreas. It would be interesting to look at this pathway in PAAD.  Descriptive plots for cell lines used by DepMap Plan The plots to make:\n CGC mutations  The plots are shown below.\nCGC Mutations A plot showing the mutations to CGC genes in each cell line was made for each cancer. A dot in the tile indicates that it is a known hotspot mutation.\n","date":1572480000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1572480000,"objectID":"e9b3b4a11f3bf12db0e28f96994908fe","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-31/","publishdate":"2019-10-31T00:00:00Z","relpermalink":"/post/2019-10-31/","section":"post","summary":"Notes from Haigis Lab Retreat 2019 Below are just a few scattered notes from the Haigis Lab Retreat 2019:\n Channing Der just published on G12R declaring it relies on a KRAS-independent macropinocyctosis pathway available in the pancreas. It would be interesting to look at this pathway in PAAD.  Descriptive plots for cell lines used by DepMap Plan The plots to make:\n CGC mutations  The plots are shown below.","tags":[],"title":"2019-10-31","type":"post"},{"authors":[],"categories":[],"content":" Comutation networks Rainfall plots for top interactions (cont.) The last thing I wanted to try was to see what the comutation interactions looked like. I also added an annotation bar below to denote the KRAS allele of each sample.\nCOAD A146T comutation\nG12D Comutation\nG13D Exclusive\nG13D Comutation\nLUAD G12A Comutation\nG12C Exclusive\nG12V Comutation\nG12V Exclusive\nMM Q61H Comutation\nQ61H Exclusive\nPAAD G12V Comutation\nG12R Comutation\nLASSO-penalized logistic regression on DepMap I didn\u0026rsquo;t have much time left, so I decided to try something a bit more ambitious. I decided to try LASSO-penalized logistic regression. Instead of regressing on the KRAS allele with one gene at a time, I regressed using all of the gene effects, simultaneously.\nGood source for penalized logistic regression: Penalized Logistic Regression Essentials in R: Ridge, Lasso and Elastic Net\nThis analysis was appended to the end of \u0026ldquo;src/30_10_logisitic-regression-syn-let.R\u0026rdquo;.\nBecause the data set is rather small - there are a lot of features/dimensions, but only a small number of rows - I used leave-one-out CV.\nEven just trying to separate WT and mutant KRAS failed. There is just not enough data to work in that many dimensions.\nThe code is still available under the section \u0026ldquo;LASSO-penalized logistic regression.\u0026rdquo;\nLDA on DepMap I tried using linear discriminant analysis to separate the cell lines from DepMap by KRAS allele.\nThis analysis was conducted in \u0026ldquo;src/30_20_discriminant-analysis-syn-let\u0026rdquo;\nThe separation is lack-luster to say the least.\nThere are simply not enough cell lines for this high-dimensional of an analysis.\n","date":1572220800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1572220800,"objectID":"7775065135c4da25e84472da120e2070","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-28/","publishdate":"2019-10-28T00:00:00Z","relpermalink":"/post/2019-10-28/","section":"post","summary":"Comutation networks Rainfall plots for top interactions (cont.) The last thing I wanted to try was to see what the comutation interactions looked like. I also added an annotation bar below to denote the KRAS allele of each sample.\nCOAD A146T comutation\nG12D Comutation\nG13D Exclusive\nG13D Comutation\nLUAD G12A Comutation\nG12C Exclusive\nG12V Comutation\nG12V Exclusive\nMM Q61H Comutation\nQ61H Exclusive\nPAAD G12V Comutation\nG12R Comutation\nLASSO-penalized logistic regression on DepMap I didn\u0026rsquo;t have much time left, so I decided to try something a bit more ambitious.","tags":[],"title":"2019-10-28","type":"post"},{"authors":[],"categories":[],"content":" Comutation networks Rainfall plots for top interactions (cont.) I started by getting oncoplot() and oncostrip() from [\u0026lsquo;maftools\u0026rsquo;]() working. The plots looked interesting so I continued this further to produce more customized plots.\nI want to plot the waterfall oncoplots with KRAS separated into one allele against the others. I want these two groups to be at the top of the order for the genes, so I needed to sort the genes myself. In order to get this parameterization from oncostrip(), I needed to update \u0026lsquo;maftools\u0026rsquo; which meant updated BioConductor to version 3.9.\nAfter updating the BioConductor and all related packages, I finished creating the oncoplots for the alleles. I made plots showing each allele and its mutually exclusive partners, separating the KRAS bar into the allele and \u0026ldquo;other\u0026rdquo;. Because I wanted to keep the allele and KRAS \u0026ldquo;other\u0026rdquo; as the top 2 rows in the plots, I had to implement my own sorting methods.\nBelow are some examples of the output. They seem to demonstrate the concept very well - there is a clear reduced rate of mutation in the indicated genes compared to the other KRAS-mutant samples and KRAS WT samples.\nCOAD LUAD PAAD Notes for tomorrow Use LDA on the DepMap data to separate the alleles. What genes are the most descriptive of the new axes?\n","date":1572134400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1572134400,"objectID":"6509210f329a3c2d22ee4d4cc5f61b4b","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-27/","publishdate":"2019-10-27T00:00:00Z","relpermalink":"/post/2019-10-27/","section":"post","summary":"Comutation networks Rainfall plots for top interactions (cont.) I started by getting oncoplot() and oncostrip() from [\u0026lsquo;maftools\u0026rsquo;]() working. The plots looked interesting so I continued this further to produce more customized plots.\nI want to plot the waterfall oncoplots with KRAS separated into one allele against the others. I want these two groups to be at the top of the order for the genes, so I needed to sort the genes myself.","tags":[],"title":"2019-10-27","type":"post"},{"authors":[],"categories":[],"content":" Logistic Regression This analysis was done in \u0026ldquo;src/30_10_logisitic-regression-syn-let.R\u0026rdquo;.\nInstead of regressing on all of the alleles at once using a multinomial logistic regression, I began by trying to use a logistic model to regress on each allele one-at-a-time comparing it to all of the others. The reasons for not using the multinomial model are described on 2019-10-24.\nThe results were rather disappointing. There were very few significant findings for COAD (1) and PAAD (2) and the ones for LUAD (458) were not very convincing when plotted. Since there were only a few, I save the plots for the hits for COAD and PAAD.\nCOAD PAAD LUAD I was planning on doing a LASSO logistic regression, regressing on the alleles with all of the genes at once, but there are not enough samples to split into training and test sets for calculating the $\\lambda$ with cross validation.\nConclusion Seeing these results, I do not think it is worth further pursuing logistic regression for this analysis.\nComutation networks Minimum p-value for exclusivity test I have finally gone back to the munging of the results of the RC-test and included the minimum p-value. The minimum p-value I used is the one recommend by the WExT paper:\n We assume that there is a nonzero probability that a gene is mutated in a sample, and thus set [the weight to] $\\frac{1}{2N}$ when no mutation in gene $g_i$ is observed in sample $s_j$\u0026hellip;\n \u0026ndash; [\u0026ldquo;A weighted exact test for mutually exclusive mutations in cancer.\u0026rdquo; Leiserson et al., 2016]\nTherefore, the lowest p-values will be $\\frac{1}{2 \\times 10000}$.\nFollowing these changes, I re-ran all downstream analyses.\nNew exploratory plots I created a few more exploratory plots that help visualize the results from the RC test a bit better.\nThe first two below show the distribution of p-values from the RC-test and Fisher\u0026rsquo;s exact test.\nThe next plot shows the distribution of the effect size of the mutually exclusive interactions found with the RC-test. The x-axis is the log-transformed p-value and the y-axis is the ratio of the number of mutually exclusive events and the number of samples in the cancer. Each dot is a gene found to have a significant mutually exclusive interaction with the allele that its color points to. The size and transparency of each dot indicate the mutational frequency of the gene.\nRainfall plots for top interactions As I discussed in yesterday\u0026rsquo;s notebook, Jake Lee (Park Lab) mentioned that I should use a rainfall plot to show some of the mutually exclusive and comutation interactions, the standard visualization for these analyses.\nThis analysis was conducted in \u0026ldquo;src/20_50_rainfall-plots.R\u0026rdquo;.\nI began by working to conform to the MAF format so that I could use \u0026lsquo;maftools\u0026rsquo;. This process went over my memory budget and canceled my R session. I took this as a good stopping point for the day\u0026hellip;\n","date":1572048000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1572048000,"objectID":"9c2e3748276bc2ed5761a58c154ca520","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-26/","publishdate":"2019-10-26T00:00:00Z","relpermalink":"/post/2019-10-26/","section":"post","summary":"Logistic Regression This analysis was done in \u0026ldquo;src/30_10_logisitic-regression-syn-let.R\u0026rdquo;.\nInstead of regressing on all of the alleles at once using a multinomial logistic regression, I began by trying to use a logistic model to regress on each allele one-at-a-time comparing it to all of the others. The reasons for not using the multinomial model are described on 2019-10-24.\nThe results were rather disappointing. There were very few significant findings for COAD (1) and PAAD (2) and the ones for LUAD (458) were not very convincing when plotted.","tags":[],"title":"2019-10-26","type":"post"},{"authors":[],"categories":[],"content":" Meeting with GM I didn\u0026rsquo;t have any time to work on this project today. I did meet with GM to go over a few things about his scripts and the figures, It went well and he seemed pleased with the current status and my proposed changes.\nBecause I couldn\u0026rsquo;t do any coding today, I took some time in the evening to brainstorm for the project. My thoughts are below.\nBrainstorming Fixing the last panel of Figure 2 One thing I want to change is the end of Figure 2. GM told me that the y-axis is not strictly the probability of getting the mutation. This is what Kevin, Peter, and I thought that it represented, but it doesn\u0026rsquo;t according to GM. We want to show the observed frequency of the alleles compared to their predicted frequency based on the trinucleotide context. The reader should look at this plot, read the axes as \u0026ldquo;observed vs. predicted\u0026rdquo; and immediately have a strong understanding concept of what is shown. There is a paper that previously looked at this for the KRAS alleles; I should go see how they did the calculation.\nLogisitic regression for synthetic lethality I began working on logistic regression for the synthetic lethality - regressing on the KRAS allele with the gene effect as the predictor. I am still working on it, and it seems like a logical analysis to attempt. According to my notes from yesterday, my next attempt is to run a logistic regression on each allele vs. the rest.\nIn addition, I could try a logistic LASSO with a logistic regression on the KRAS alleles using all of the alleles as predictors. From a quick Google search, this seems like a good place to start: Penalized Logistic Regression Essentials in R: Ridge, Lasso and Elastic Net.\nComparing overall dependencies of cell lines by KRAS alleles GM had a good idea during our meeting (credit where credit is due). He suggested looking at the overall distribution of lethal genes in the cell lines of each KRAS allele. I am picturing a \u0026lsquo;ggridges\u0026rsquo; plot, one for each allele. The thought was that perhaps \u0026ldquo;stronger\u0026rdquo; alleles will have fewer dependencies. The tricky part will be figuring out which genes to include. I should start by including all of the genes, though it is unlikely to show a difference between any of the alleles. I can also use information from the essential and nonessential genes. I would be interesting to just see the distributions for the \u0026ldquo;pan-essential\u0026rdquo; genes.\nOn a similar note, what about histograms for the genes in the KEGG pathways, CGC genes, and BioID genes? Normalize within a gene, and then show \u0026lsquo;ggridges\u0026rsquo; for the genes in each of those. Then, underneath, a heatmap of the most variable genes in the gene set showing their values in the cell lines. (I included a quick sketch in my notebook relating this thought.) I could also do this for any gene sets found to be enriched in the genes in the whole-cancer heatmap (not within individual clusters - they are too small), or with the gene sets found to be enriched in GSEA.\nA term for reduced comutation but not mutual exclusivity We need a different term than \u0026ldquo;mutually exclusive\u0026rdquo; when referring to genes that frequently mutate with a KRAS allele, just less often than would be predicted by random. The term \u0026ldquo;mutually exclusive\u0026rdquo; should be saved for BRAF and EGFR-like interactions, but not for TP53. However, I do not want to call it reduced comutation. (GM mentioned that I had used a good term a little while ago, but couldn\u0026rsquo;t recall it, I should look in the manuscript to see if it is there.) This is essential for the believability of the paper.\nFor plotting, we will want to come up with a heurisitc for separating between these three classes. Comutation and the others are easy, but between BRAF-like interactions and TP53-like interactions will be a bit trickier.\nComutation networks I need to use more stringent cutoffs for p-value, genetic events, and overall frequency of mutation before continuing further. I can also include supplemental plots for the distribution and cumulative distribution of these metrics.\nJake Lee (Park Lab) brought up the good idea of representing the comutation and reduced comutation genes using a canonical rainfall plot. My hesitation is because a lot of these events occur at low frequencies, the plot will be very sparse and unimpressive. For example, the PORCN comutation interaction with A146T in COAD is interesting because it is mutated in 3 or 4 of the A146T samples and about the same number of other samples. Just given the first value, the interaction seems uninteresting; the second value provides context. The ratio of these two values is the odds ratio, so perhaps somehow using that will increase the potency. Maybe a rainfall plot with the color representing the OR? If I can figure out a good plot for these interactions, then I can dive further into a few in particular to make some hypotheses (eg. what are the PORCN mutations?, are these likely disruptive?, are they located on the same part of the protein?, etc.)\nFor the rainfall plots, one tricky part will be deciding what genes to include. A few options are:\n For each allele, the genes with the most number of interactions. For each allele, the genes with the highest OR. Enriched gene sets across all of the hits. A priori selected gene sets.  I think this should give me plenty to work on, for now.\n","date":1571961600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1571961600,"objectID":"1724bfb76f670def355820b69163cc3c","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-25/","publishdate":"2019-10-25T00:00:00Z","relpermalink":"/post/2019-10-25/","section":"post","summary":"Meeting with GM I didn\u0026rsquo;t have any time to work on this project today. I did meet with GM to go over a few things about his scripts and the figures, It went well and he seemed pleased with the current status and my proposed changes.\nBecause I couldn\u0026rsquo;t do any coding today, I took some time in the evening to brainstorm for the project. My thoughts are below.","tags":[],"title":"2019-10-25","type":"post"},{"authors":[],"categories":[],"content":" Allele-specific synthetic lethality I am revisiting the allele-specific synthetic lethality. Yesterday, I increased the stringency for the cutoffs by declaring the p-value threshold for the ANOVA across genes to be 0.01. This reduced the number of genes, as expected, but also made the heatmaps for believable and striking. I think it is the correct choice considering we cannot use an FDR adjusted cutoff in this case. The problem that I have run into now is that the functional enrichment does not turn out anything of remarkable interest for COAD and PAAD. LUAD still has quite a few hits, so I may be able to use those.\nMultinomial logistic regression Introduction I tried to use multinomial logistic regression to identify allele-specific synthetic lethality. The model regressed on the allele of the cell lines and used the gene effect as the covariate. This analysis was completed in \u0026ldquo;src/30_10_logisitic-regression-syn-let.R\u0026rdquo;.\nSources https://stats.idre.ucla.edu/r/dae/multinomial-logistic-regression/\nThe model The model had the following form:\nallele ~ gene_effect  If available, \u0026ldquo;WT\u0026rdquo; was set as the baseline. Otherwise (for PAAD) the first allele alphabetically (G12D) was the intercept. The problem with this approach was that all of the comparisons were to the WT allele. This was even worse for PAAD where the comparison was to G12D.\nTherefore, I instead tried to run the same model but comparing each allele to the rest using a binomial (normal) logistic regression. I will have to do this tomorrow.\nI fixed an issue with the parsing of the gene names from depmap19Q3.Achilles.gene.dependency and depmap19Q3.Achilles.gene.effect. Gene names that normally have a hyphen instead had a period in their names. Therefore, they were split where there should have been a hyphen. This is unlikely to have a large effect on the results.\nI re-ran the downstream munging script \u0026ldquo;munge/15_depmap19Q3_model-data-prep.R\u0026rdquo;. I re-ran 10 and 30 group of scripts (linear modeling and logistic modeling).\n","date":1571875200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1571875200,"objectID":"99f99dc1b2998742b48f338b304591c4","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-24/","publishdate":"2019-10-24T00:00:00Z","relpermalink":"/post/2019-10-24/","section":"post","summary":"Allele-specific synthetic lethality I am revisiting the allele-specific synthetic lethality. Yesterday, I increased the stringency for the cutoffs by declaring the p-value threshold for the ANOVA across genes to be 0.01. This reduced the number of genes, as expected, but also made the heatmaps for believable and striking. I think it is the correct choice considering we cannot use an FDR adjusted cutoff in this case. The problem that I have run into now is that the functional enrichment does not turn out anything of remarkable interest for COAD and PAAD.","tags":[],"title":"2019-10-24","type":"post"},{"authors":[],"categories":[],"content":" Plots for specific types of genes (cont.) (This was started on 2019-10-21.)\nThe gene sets have been prepared earlier. There was a bug though - each gene set was using the path to the KEA file. This was fixed.\nI couldn\u0026rsquo;t decide on whether or not to normalize the depletion effect scores for the plots. If I don\u0026rsquo;t, then most of the differences are between genes, but if I do, then the y-axis is essentially meaningless. I decided to scale the values, but I may want to revisit this decision.\nThe plots for the specific gene types for the clusters are in \u0026ldquo;graphs/10_17_linear-modeling-syn-let_specific-protein-types/\u0026ldquo;.\nI decided to return to the original clustering to find more conservative/believable results. Therefore, I reduced the p-value cutoff for the ANOVA to p-value \u0026lt; 0.01. This obviously reduced the number of hits, but also created tighter clusters. Below are the new heatmaps (though they will replace the originals in a previous notebook, anyways).\nCOAD LUAD PAAD The number of hits for COAD and PAAD were significantly reduced to where I could show the gene names. LUAD still has many hits.\nThe functional enrichment clustering did not turn up much for COAD, plenty for LUAD, and a few kinases/hubs for PAAD. I will continue working on this, tomorrow.\nSlight digression to make plots for KH\u0026rsquo;s presentation. They were plots of the high-level genetic interactions for G12V across the cancers. They are in \u0026ldquo;graphs/20_40_highlivel-genetic-interactions/\u0026ldquo;.\nplot idea: enriched gene sets from genetic interactions vs. enriched gene sets from syn. let.\nNotes on KH\u0026rsquo;s CRUK presentation  the size of networks is in part determined by statistical use biological \u0026ldquo;priors\u0026rdquo; to prioritize hits  ","date":1571788800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1571788800,"objectID":"72c0cb5f951d58e9218b2ca9a93845f0","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-23/","publishdate":"2019-10-23T00:00:00Z","relpermalink":"/post/2019-10-23/","section":"post","summary":"Plots for specific types of genes (cont.) (This was started on 2019-10-21.)\nThe gene sets have been prepared earlier. There was a bug though - each gene set was using the path to the KEA file. This was fixed.\nI couldn\u0026rsquo;t decide on whether or not to normalize the depletion effect scores for the plots. If I don\u0026rsquo;t, then most of the differences are between genes, but if I do, then the y-axis is essentially meaningless.","tags":[],"title":"2019-10-23","type":"post"},{"authors":[],"categories":[],"content":" Preparing for CRUK presentation OP and I decided that I should just present the comutation project at today\u0026rsquo;s CRUK in-person meeting for the trainees. I made new versions of the genetic interaction networks with thicker edges to be more easily viewed on the screens.\nThe final presentation was copied to \u0026ldquo;presentations/2019.10.21_CRUK.pptx\u0026rdquo;.\n","date":1571702400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1571702400,"objectID":"5ff920cc68b551dc9c5ccf3e650561e2","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-22/","publishdate":"2019-10-22T00:00:00Z","relpermalink":"/post/2019-10-22/","section":"post","summary":"Preparing for CRUK presentation OP and I decided that I should just present the comutation project at today\u0026rsquo;s CRUK in-person meeting for the trainees. I made new versions of the genetic interaction networks with thicker edges to be more easily viewed on the screens.\nThe final presentation was copied to \u0026ldquo;presentations/2019.10.21_CRUK.pptx\u0026rdquo;.","tags":[],"title":"2019-10-22","type":"post"},{"authors":[],"categories":[],"content":" Plots for specific types of genes Sources Transcription Factors\nI found a list of transcription factors from the TF2DNA Database. In the \u0026ldquo;Downloads\u0026rdquo; tab, I downloaded and unarchived the \u0026ldquo;TF matrix files\u0026rdquo;. The file names were taken as a list of transcription factors.\nI also used the ChEA_2106 gene set from Enrichr that pulled data from ChEA. The names of the gene sets contained transcription factors.\nHubs of the PPIN\nThe PPI_Hub_Proteins gene set was taken from Enrichr. The original data source was X2Kweb.\nKinases\nA list of kinases was acquired from the Kinase Enrichment Aalysis. The actual gene set was taken from Enrichr: KEA_2015.\nCell Cycle Regulators\nA list of cell-cycle regulators was taken from KEGG\u0026rsquo;s CELL_CYCLE gene set and Reactome\u0026rsquo;s CELL_CYCLE_MITOTIC gene set. The gene sets were taken from the MSigDB C2 list.\nThe preparation of each of these data sets was added to \u0026ldquo;munge/37_gene-list-preparation.R\u0026rdquo;.\n","date":1571616000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1571616000,"objectID":"6ccad3897f34be257e7ffc56714949bf","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-21/","publishdate":"2019-10-21T00:00:00Z","relpermalink":"/post/2019-10-21/","section":"post","summary":"Plots for specific types of genes Sources Transcription Factors\nI found a list of transcription factors from the TF2DNA Database. In the \u0026ldquo;Downloads\u0026rdquo; tab, I downloaded and unarchived the \u0026ldquo;TF matrix files\u0026rdquo;. The file names were taken as a list of transcription factors.\nI also used the ChEA_2106 gene set from Enrichr that pulled data from ChEA. The names of the gene sets contained transcription factors.\nHubs of the PPIN","tags":[],"title":"2019-10-21","type":"post"},{"authors":[],"categories":[],"content":" Analysis of GSEA results (cont.) Yesterday, I was able to plot the results from the GSEA before the end of the day. The plots of the GSEA results don\u0026rsquo;t show anything terribly interesting. Dot-plots for each cancer are shown below. The gene set is displayed if it has a Normalized Enrichment Score (NES) of greater than 1.2 or less than -1.2 and a FDR-adjusted p-value of less than 0.20.\nCOAD LUAD PAAD Quick side note - I was curious about the relationship between the dependency on NF1 and KRAS allele in COAD cell lines. I therefore made a quick bar-plot showing this relationship in \u0026ldquo;src/90_10_NF1-depletion-COAD.R\u0026rdquo;. I\u0026rsquo;m not sure how to interpret the results, but will show KH.\nAnalysis of gene clusters from simple DepMap model. I looked for weakly connected components in the STRING PPI with the genes from each cluster of genes (with at least 4 nodes). To be clear, these are the same clusters as those shown in the heatmaps. Plots of all the components are in \u0026ldquo;graphs/10_15_linear-modeling-syn-let_ppi-subnetworks/\u0026ldquo;. Some are shown below.\nCOAD LUAD PAAD To-Do For synthetic lethal portion:\n specific plots for types of genes in the gene clusters  transcription factors hubs in PPI chromatin modifiers cell cycle   For comutation portion:\n plot p-value vs. cumulative number of genes for comutation and mutually exclusive plot p-value vs. number of events for co-mutation and mutual exclusivity  ","date":1571356800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1571356800,"objectID":"be03b0b318660d64c099a3477ece56a7","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-18/","publishdate":"2019-10-18T00:00:00Z","relpermalink":"/post/2019-10-18/","section":"post","summary":"Analysis of GSEA results (cont.) Yesterday, I was able to plot the results from the GSEA before the end of the day. The plots of the GSEA results don\u0026rsquo;t show anything terribly interesting. Dot-plots for each cancer are shown below. The gene set is displayed if it has a Normalized Enrichment Score (NES) of greater than 1.2 or less than -1.2 and a FDR-adjusted p-value of less than 0.20.","tags":[],"title":"2019-10-18","type":"post"},{"authors":[],"categories":[],"content":" Analysis of GSEA results (cont.) I created dot-plots that show which gene sets are enriched for each allele in each cancer. They plots are available in \u0026ldquo;graphs/10_37_gsea-depmap-analysis/\u0026ldquo;.\nAfter looking at the results from just using the Hallmarks of Cancer gene set, I re-ran the GSEA to include the C2 Curated gene sets. This took way too long, though, so I remake the script to run as a job-array. For some reason, the 11th and final job (PAAD G12V) failed due to X11 errors. The log is shown below:\nslurmstepd: error: x11: job infos are invalid slurmstepd: error: spank: required plugin x11.so: user_init() failed with rc=- slurmstepd: error: spank_user failed. slurmstepd: error: Unable to return to working directory slurmstepd: error: job_manager exiting abnormally, rc = 4020  I just ran another job array with --array=11-11 and it worked.\nAll jobs were successfully running by 2:15 pm. From my notes the last time I ran GSEA suing Hallmark and C2 gene sets, this should take about 5 hours.\nDescribing genes in clusters of simple model results On 10\u0026frasl;14, I created the heatmaps in \u0026ldquo;graphs/10_10_linear-modeling-syn-let_pheatmaps\u0026rdquo;. The genes were cut into clusters by eye. I now want to use Enrichr to describe the genes in each cluster. This analysis was conducted in \u0026ldquo;src/10_10_linear-modeling-syn-let.R\u0026rdquo; in the section \u0026ldquo;Functional annotation of heatmap gene (row) clusters\u0026rdquo;. Tables of the outputs are available in \u0026ldquo;tables/10_10_linear-modeling-syn-let\u0026rdquo;; two tables are available, one with all of the significant hits (adjusted q-value \u0026lt; 0.20) and one with the top 5 from each data source for each gene cluster. This second table is also filtered for terms that are unique compared to the terms in the other clusters (ie. the term was only found for one cluster of genes). A third table was created after removing some of the more common terms: \u0026ldquo;gene-clusters-fxnal-enrichment_uncommon.tsv\u0026rdquo;.\n","date":1571270400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1571270400,"objectID":"be2c3f9cc250dc80c6bff69759a65b87","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-17/","publishdate":"2019-10-17T00:00:00Z","relpermalink":"/post/2019-10-17/","section":"post","summary":"Analysis of GSEA results (cont.) I created dot-plots that show which gene sets are enriched for each allele in each cancer. They plots are available in \u0026ldquo;graphs/10_37_gsea-depmap-analysis/\u0026ldquo;.\nAfter looking at the results from just using the Hallmarks of Cancer gene set, I re-ran the GSEA to include the C2 Curated gene sets. This took way too long, though, so I remake the script to run as a job-array. For some reason, the 11th and final job (PAAD G12V) failed due to X11 errors.","tags":[],"title":"2019-10-17","type":"post"},{"authors":[],"categories":[],"content":" Analysis of GSEA results The code for this section is in \u0026ldquo;src/10_37_gsea-depmap-analysis.R\u0026rdquo;.\nPicking up from yesterday, I began by analyzing the GSEA results. I didn\u0026rsquo;t get very far before having to spend the rest of the day on other nonsense.\n","date":1571184000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1571184000,"objectID":"5a45c6f949b443b3bb7df415e95867ba","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-16/","publishdate":"2019-10-16T00:00:00Z","relpermalink":"/post/2019-10-16/","section":"post","summary":"Analysis of GSEA results The code for this section is in \u0026ldquo;src/10_37_gsea-depmap-analysis.R\u0026rdquo;.\nPicking up from yesterday, I began by analyzing the GSEA results. I didn\u0026rsquo;t get very far before having to spend the rest of the day on other nonsense.","tags":[],"title":"2019-10-16","type":"post"},{"authors":[],"categories":[],"content":" GSEA of DepMap The script \u0026ldquo;src/10_30_gsea-depmap-preparation.R\u0026rdquo; prepares the input data for GSEA.\nThe bash script \u0026ldquo;src/10_35_gsea-depmap.sh\u0026rdquo; runs all of the GSEA tests.\nData preparation GSEA User Guide\nGSEA Data Formats\nExpression Data Set\nIt is a tab-delimted file (extension .txt) with the following format:\n   NAME DESCRIPTION sample1 sample2 sample3     gene1 na      gene2 na       For this analysis, the DepMap gene effect values are used in place of RNA expression.\nPhenotype Labels\nA normal text file with extension .cls and the following format:\n{numberOfSamples} {numberOfClasses} 1 # {class0Name} {class1Name} 0 0 0 0 0 0 1 1 1 1 1  Gene Sets\nI downloaded gene sets from MSigDB to \u0026ldquo;data/gsea/\u0026rdquo; and added the directory to the ignore list.\nRunning GSEA The following command runs the script. It first removes all of the previous results.\nsbatch src/10_35_gsea-depmap.sh  To-Do Tomorrow Tomorrow, I need to parse the results of the GSEA and address the first portion of the To-Do from yesterday:\n Tomorrow, I would like to figure out a way of partitioning the allele-specific synthetic lethality hits so I can do a functional enrichment test. Perhaps, I can use the groups from the heatmap clusters.\n ","date":1571097600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1571097600,"objectID":"4f7111b1e5b24178fd64970539d57cb7","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-15/","publishdate":"2019-10-15T00:00:00Z","relpermalink":"/post/2019-10-15/","section":"post","summary":"GSEA of DepMap The script \u0026ldquo;src/10_30_gsea-depmap-preparation.R\u0026rdquo; prepares the input data for GSEA.\nThe bash script \u0026ldquo;src/10_35_gsea-depmap.sh\u0026rdquo; runs all of the GSEA tests.\nData preparation GSEA User Guide\nGSEA Data Formats\nExpression Data Set\nIt is a tab-delimted file (extension .txt) with the following format:\n   NAME DESCRIPTION sample1 sample2 sample3     gene1 na      gene2 na       For this analysis, the DepMap gene effect values are used in place of RNA expression.","tags":[],"title":"2019-10-15","type":"post"},{"authors":[],"categories":[],"content":" Summarizing current status of comutation analysis Before continuing, it seemed reasonable to summarize the current status of the comutation and mutual exclusivity analysis. This summary is located in Comutation and Mutual Exclusivity.\nI changed the thresholds for the comutation and mutual exclusivity results in \u0026ldquo;src/20_35_rc-fisher-comparison.R\u0026rdquo; to be more strict because the numbers of interactions detected seemed unbelievably high. I then re-ran all downstream analyses.\nI fixed a bug in the dot-plots of the Enrichr results. If there were no 0 values, then the minimum number would be set to zero for the alpha and point size. Now, the minimum values for the alpha and point size are 0.1 and 1, respectively, if there are no zero values.\nFinishing off the summary on the comutation analysis, I turned my attention back to the synthetic lethality portion of the project.\nContinuing with simple linear model of allele-specific synthetic lethality I created heatmaps of the signficiant results from the simple model of allele-specific synthetic lethality. They are intended to give an over view of the number of genes and also the intensity of the differences found.\nCOAD LUAD PAAD To-Do Tomorrow Tomorrow, I would like to figure out a way of partitioning the allele-specific synthetic lethality hits so I can do a functional enrichment test. Perhaps, I can use the groups from the heatmap clusters.\nI also want to run the GSEA/GSVA/ssGSEA for the synthetic lethality. I need to look back at what these methods do before deciding on which to start with.\n","date":1571011200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1571011200,"objectID":"23b8b68a0da387315b0da514dc951acf","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-14/","publishdate":"2019-10-14T00:00:00Z","relpermalink":"/post/2019-10-14/","section":"post","summary":"Summarizing current status of comutation analysis Before continuing, it seemed reasonable to summarize the current status of the comutation and mutual exclusivity analysis. This summary is located in Comutation and Mutual Exclusivity.\nI changed the thresholds for the comutation and mutual exclusivity results in \u0026ldquo;src/20_35_rc-fisher-comparison.R\u0026rdquo; to be more strict because the numbers of interactions detected seemed unbelievably high. I then re-ran all downstream analyses.\nI fixed a bug in the dot-plots of the Enrichr results.","tags":[],"title":"2019-10-14","type":"post"},{"authors":[],"categories":[],"content":" Bug fix At the end of yesterday, I noticed the following bug:\n There is a bug where not all of the interactions are being included. For example, BRAF is only connected to G13D in the KEGG-specific interaction network.\n After a bit of digging I found that the BRAF mutations were being labeled as significant, but were filtered out by the filter(num_mut_per_cancer \u0026gt;= 3) in \u0026ldquo;src/20_35_rc-fisher-comparison.R\u0026rdquo;. The problem was that the \u0026ldquo;num_mut_per_cancer\u0026rdquo; column was NA for all of the alleles except for one, G13D.\nTherefore, I adjusted \u0026ldquo;munge/30_rc-test_results-prep.R\u0026rdquo; to fix this bug. The problem was with a data frame merging by, among other columns, KRAS allele. However, since there are 0 comutation events between BRAF and some of the alleles, the values were NA not zero.\nA test was added to make sure this is fixed (available in \u0026ldquo;tests/test-30_rc-test_results-prep.R\u0026rdquo;).\nAll of the dependent files were re-run and the figures should now be accurate.\nFunctional Enrichment (cont.) The results from the functional enrichment were written to Excel and TSV files for independent analysis. The data frame was also cached.\nI tried multiple plotting modalities to help with parsing the results. The attempts included a network and bar-plots, but finally settled on a dot-plot for each data source. The x and y-axes are the KRAS allele and enriched terms, respectively. The size and color of the dots indicate the \u0026ldquo;strength\u0026rdquo; of the association by representing the p-value and number of genes with genetic interactions in the gene set, respectively. I made one plot for each data source and cancer combination. A few examples are shown below.\nCOAD The following plot is of the Kinase Enrichment Analysis (KEA) gene sets in COAD.\nThe plot below is showing the enriched gene sets made up of the protein-protein interaction networks of transcription factors.\nLUAD The following plot shows the pathways (from the PANTHER data base) enriched in the genetic interactions of KRAS alleles in LUAD.\nMM The following plot shows the pathways (from the PANTHER database) enriched in the genetic interactions of KRAS alleles in MM.\nIn addition, the following shows the same, but using the BioCarta database instead.\nKEA The following plot is of the Kinase Enrichment Analysis (KEA) gene sets in PAAD.\nThe following plot shows the pathways (from the PANTHER database) enriched in the genetic interactions of KRAS alleles in LUAD.\nIn addition, the following shows the same, but using the WikiPathways database instead.\n","date":1570838400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570838400,"objectID":"c950eb58b7b5a743f68403872429e5ea","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-12/","publishdate":"2019-10-12T00:00:00Z","relpermalink":"/post/2019-10-12/","section":"post","summary":"Bug fix At the end of yesterday, I noticed the following bug:\n There is a bug where not all of the interactions are being included. For example, BRAF is only connected to G13D in the KEGG-specific interaction network.\n After a bit of digging I found that the BRAF mutations were being labeled as significant, but were filtered out by the filter(num_mut_per_cancer \u0026gt;= 3) in \u0026ldquo;src/20_35_rc-fisher-comparison.R\u0026rdquo;. The problem was that the \u0026ldquo;num_mut_per_cancer\u0026rdquo; column was NA for all of the alleles except for one, G13D.","tags":[],"title":"2019-10-12","type":"post"},{"authors":[],"categories":[],"content":" Analysis of hits from genetic interaction tests (cont.) I began by fixing the UpSet plots such that they now include all sets and intersections. (The updated images are shown in yesterday\u0026rsquo;s notebook.)\nA priori gene lists For the figure, I see the \u0026ldquo;cloud\u0026rdquo; (ie. high-level) network adjacent to the UpSet plots to describe that the comutation patterns are distinct between the alleles. Then, the next two logical questions would be:\n Are there any important/notable genes in there? Are any specific functions enriched for the alleles?  I began this follow up with the first question. As noted in yesterday\u0026rsquo;s notebook, I have gathered the following gene lists:\n the following KEGG gene sets (from MSigDB) (a full list is available at the end of this notebook):  apoptosis, cell-cycle ERBB signaling pathway Hedgehog signaling pathway MAPK signaling pathway mTOR signaling pathway Notch signaling pathway p53 signaling pathway VEGF signaling pathway WNT signaling pathway  the interactors with WT KRAS from Kovalski et al., 2019 and the COSMIC Cancer Gene Consensus  The analysis was conducted in \u0026ldquo;src/20_43_apriori-lists-genetic-interactions.R\u0026rdquo;.\nDuring the analysis, I had to go back to \u0026ldquo;munge/30_rc-test_results-prep.R\u0026rdquo; and \u0026ldquo;src/20_35_rc-fisher-comparison.R\u0026rdquo; to fix some filtering mistakes. Their effects on the results were minor.\nThe resulting plots are shown below. For some of the LUAD and PAAD, I present separate plots for each source of gene list to keep the plot legible.\nCOAD LUAD KEGG pathways\nPhysical Interactors\nCGC Genes\nMM PAAD KEGG pathways\nPhysical Interactors\nCGC Genes\nA few comments  There are some genes that comutate with one allele and are mutually exclusive with another. This is something to look into. There are some obvious stand-outs in terms of how \u0026ldquo;strong\u0026rdquo; (low p-value) the interaction is. Again, these are likely worth further investigation.  Functional Enrichment Instead of using specific gene lists chosen for a priori reasons, I used a statistical tool to identify biological functions that are enriched in the list of genes identified to have a genetic interaction with a KRAS allele.\nErncihR The first attempt used the Enrichr (Chen et al., 2013) tool available through a R API using the \u0026lsquo;enrichR\u0026rsquo; package (link to the web API).\nThe following data bases were used:\n \u0026ldquo;BioCarta_2016\u0026rdquo;, \u0026ldquo;GO_Biological_Process_2018\u0026rdquo;, \u0026ldquo;KEA_2015\u0026rdquo;, \u0026ldquo;KEGG_2019_Human\u0026rdquo;, \u0026ldquo;LINCS_L1000_Kinase_Perturbations_down\u0026rdquo;, \u0026ldquo;LINCS_L1000_Kinase_Perturbations_up\u0026rdquo;, \u0026ldquo;Panther_2016\u0026rdquo;, \u0026ldquo;PPI_Hub_Proteins\u0026rdquo;, \u0026ldquo;Reactome_2016\u0026rdquo;, \u0026ldquo;Transcription_Factor_PPIs\u0026rdquo;, \u0026ldquo;WikiPathways_2019_Human\u0026rdquo;  A complete list can be found using the following command in R.\nsort(enrichR::listEnrichrDbs()$libraryName)  The results were filtered by adjusted p-value \u0026lt; 0.20 and at least 2 genes in the gene set. The filtered tables were written to \u0026ldquo;tables/20_45_fxnal-enrich-genetic-interactions\u0026rdquo;.\nTODO\nThere is a bug where not all of the interactions are being included. For example, BRAF is only connected to G13D in the KEGG-specific interaction network.\nFull List of KEGG Genesets GLYCOLYSIS_GLUCONEOGENESIS, CITRATE_CYCLE_TCA_CYCLE, PENTOSE_PHOSPHATE_PATHWAY, PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS, FRUCTOSE_AND_MANNOSE_METABOLISM, GALACTOSE_METABOLISM, ASCORBATE_AND_ALDARATE_METABOLISM, FATTY_ACID_METABOLISM, STEROID_BIOSYNTHESIS, PRIMARY_BILE_ACID_BIOSYNTHESIS, STEROID_HORMONE_BIOSYNTHESIS, OXIDATIVE_PHOSPHORYLATION, PURINE_METABOLISM, PYRIMIDINE_METABOLISM, ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM, GLYCINE_SERINE_AND_THREONINE_METABOLISM, CYSTEINE_AND_METHIONINE_METABOLISM, VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION, VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS, LYSINE_DEGRADATION, ARGININE_AND_PROLINE_METABOLISM, HISTIDINE_METABOLISM, TYROSINE_METABOLISM, PHENYLALANINE_METABOLISM, TRYPTOPHAN_METABOLISM, BETA_ALANINE_METABOLISM, TAURINE_AND_HYPOTAURINE_METABOLISM, SELENOAMINO_ACID_METABOLISM, GLUTATHIONE_METABOLISM, STARCH_AND_SUCROSE_METABOLISM, N_GLYCAN_BIOSYNTHESIS, OTHER_GLYCAN_DEGRADATION, O_GLYCAN_BIOSYNTHESIS, AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM, GLYCOSAMINOGLYCAN_DEGRADATION, GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE, GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE, GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE, GLYCEROLIPID_METABOLISM, INOSITOL_PHOSPHATE_METABOLISM, GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS, GLYCEROPHOSPHOLIPID_METABOLISM, ETHER_LIPID_METABOLISM, ARACHIDONIC_ACID_METABOLISM, LINOLEIC_ACID_METABOLISM, ALPHA_LINOLENIC_ACID_METABOLISM, SPHINGOLIPID_METABOLISM, GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES, GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES, GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES, PYRUVATE_METABOLISM, GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM, PROPANOATE_METABOLISM, BUTANOATE_METABOLISM, ONE_CARBON_POOL_BY_FOLATE, RIBOFLAVIN_METABOLISM, NICOTINATE_AND_NICOTINAMIDE_METABOLISM, PANTOTHENATE_AND_COA_BIOSYNTHESIS, FOLATE_BIOSYNTHESIS, RETINOL_METABOLISM, PORPHYRIN_AND_CHLOROPHYLL_METABOLISM, TERPENOID_BACKBONE_BIOSYNTHESIS, LIMONENE_AND_PINENE_DEGRADATION, NITROGEN_METABOLISM, SULFUR_METABOLISM, AMINOACYL_TRNA_BIOSYNTHESIS, METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450, DRUG_METABOLISM_CYTOCHROME_P450, DRUG_METABOLISM_OTHER_ENZYMES, BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS, ABC_TRANSPORTERS, RIBOSOME, RNA_DEGRADATION, RNA_POLYMERASE, BASAL_TRANSCRIPTION_FACTORS, DNA_REPLICATION, SPLICEOSOME, PROTEASOME, PROTEIN_EXPORT, PPAR_SIGNALING_PATHWAY, BASE_EXCISION_REPAIR, NUCLEOTIDE_EXCISION_REPAIR, MISMATCH_REPAIR, HOMOLOGOUS_RECOMBINATION, NON_HOMOLOGOUS_END_JOINING, MAPK_SIGNALING_PATHWAY, ERBB_SIGNALING_PATHWAY, CALCIUM_SIGNALING_PATHWAY, CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION, CHEMOKINE_SIGNALING_PATHWAY, PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM, NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION, CELL_CYCLE, OOCYTE_MEIOSIS, P53_SIGNALING_PATHWAY, UBIQUITIN_MEDIATED_PROTEOLYSIS, SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT, REGULATION_OF_AUTOPHAGY, LYSOSOME, ENDOCYTOSIS, PEROXISOME, MTOR_SIGNALING_PATHWAY, APOPTOSIS, CARDIAC_MUSCLE_CONTRACTION, VASCULAR_SMOOTH_MUSCLE_CONTRACTION, WNT_SIGNALING_PATHWAY, DORSO_VENTRAL_AXIS_FORMATION, NOTCH_SIGNALING_PATHWAY, HEDGEHOG_SIGNALING_PATHWAY, TGF_BETA_SIGNALING_PATHWAY, AXON_GUIDANCE, VEGF_SIGNALING_PATHWAY, FOCAL_ADHESION, ECM_RECEPTOR_INTERACTION, CELL_ADHESION_MOLECULES_CAMS, ADHERENS_JUNCTION, TIGHT_JUNCTION, GAP_JUNCTION, COMPLEMENT_AND_COAGULATION_CASCADES, ANTIGEN_PROCESSING_AND_PRESENTATION, RENIN_ANGIOTENSIN_SYSTEM, TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY, NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY, RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY, CYTOSOLIC_DNA_SENSING_PATHWAY, JAK_STAT_SIGNALING_PATHWAY, HEMATOPOIETIC_CELL_LINEAGE, NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY, T_CELL_RECEPTOR_SIGNALING_PATHWAY, B_CELL_RECEPTOR_SIGNALING_PATHWAY, FC_EPSILON_RI_SIGNALING_PATHWAY, FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS, LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION, INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION, CIRCADIAN_RHYTHM_MAMMAL, LONG_TERM_POTENTIATION, NEUROTROPHIN_SIGNALING_PATHWAY, LONG_TERM_DEPRESSION, OLFACTORY_TRANSDUCTION, TASTE_TRANSDUCTION, REGULATION_OF_ACTIN_CYTOSKELETON, INSULIN_SIGNALING_PATHWAY, GNRH_SIGNALING_PATHWAY, PROGESTERONE_MEDIATED_OOCYTE_MATURATION, MELANOGENESIS, ADIPOCYTOKINE_SIGNALING_PATHWAY, TYPE_II_DIABETES_MELLITUS, TYPE_I_DIABETES_MELLITUS, MATURITY_ONSET_DIABETES_OF_THE_YOUNG, ALDOSTERONE_REGULATED_SODIUM_REABSORPTION, VASOPRESSIN_REGULATED_WATER_REABSORPTION, PROXIMAL_TUBULE_BICARBONATE_RECLAMATION, ALZHEIMERS_DISEASE, PARKINSONS_DISEASE, AMYOTROPHIC_LATERAL_SCLEROSIS_ALS, HUNTINGTONS_DISEASE, PRION_DISEASES, VIBRIO_CHOLERAE_INFECTION, EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION, PATHOGENIC_ESCHERICHIA_COLI_INFECTION, LEISHMANIA_INFECTION, PATHWAYS_IN_CANCER, COLORECTAL_CANCER, RENAL_CELL_CARCINOMA, PANCREATIC_CANCER, ENDOMETRIAL_CANCER, GLIOMA, PROSTATE_CANCER, THYROID_CANCER, BASAL_CELL_CARCINOMA, MELANOMA, BLADDER_CANCER, CHRONIC_MYELOID_LEUKEMIA, ACUTE_MYELOID_LEUKEMIA, SMALL_CELL_LUNG_CANCER, NON_SMALL_CELL_LUNG_CANCER, ASTHMA, AUTOIMMUNE_THYROID_DISEASE, SYSTEMIC_LUPUS_ERYTHEMATOSUS, ALLOGRAFT_REJECTION, GRAFT_VERSUS_HOST_DISEASE, PRIMARY_IMMUNODEFICIENCY, HYPERTROPHIC_CARDIOMYOPATHY_HCM, ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC, DILATED_CARDIOMYOPATHY, VIRAL_MYOCARDITIS\n","date":1570752000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570752000,"objectID":"6e7a6b7c2fd2d64c8c0d5eb91b08a402","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-11/","publishdate":"2019-10-11T00:00:00Z","relpermalink":"/post/2019-10-11/","section":"post","summary":"Analysis of hits from genetic interaction tests (cont.) I began by fixing the UpSet plots such that they now include all sets and intersections. (The updated images are shown in yesterday\u0026rsquo;s notebook.)\nA priori gene lists For the figure, I see the \u0026ldquo;cloud\u0026rdquo; (ie. high-level) network adjacent to the UpSet plots to describe that the comutation patterns are distinct between the alleles. Then, the next two logical questions would be:","tags":[],"title":"2019-10-11","type":"post"},{"authors":[],"categories":[],"content":" Comparing results from Fisher\u0026rsquo;s test and RC-test Looking at GM\u0026rsquo;s figure 3, I\u0026rsquo;m not sure how he has such a sparse figure for PAAD. From his results, there should be a lot of genes for KRAS G12D (\u0026gt; 800) at even a p-value cut-off of 0.01.\nFrom yesterday\u0026rsquo;s conclusion to use the Fisher\u0026rsquo;s exact test for comutation and the RC-test for mutual exclusivity, I created a combined data frame with both of these data for future use: genetic_interaction_df.\nAnalysis of hits from genetic interaction tests This analysis was conducted in \u0026ldquo;src/20_40_genetic-interaction-hits.R\u0026rdquo;.\nFor a first pass, I just identified genes that might be of interest by using curated lists:\n the following KEGG gene sets (from MSigDB): the interactors with WT KRAS from Kovalski et al., 2019 and the COSMIC Cancer Gene Consensus  Gene list preparation These files were all parsed and cached in \u0026ldquo;munge/37_gene-list-preparation.R\u0026rdquo;\nThe BioID data was available in an Excel spreadsheet with merged cells. Therefore, it was difficult to read in and prepare as-is. I manually removed the annoying cells in a new file \u0026ldquo;Kovalski-et-al-2019_BioID_REFORMATTED.xlsx\u0026rdquo;\nThe resulting files are:\n cosmic_cgc_df kegg_geneset_df kras_interactors_bioid_df genes_of_interest_df (a collation of the genes and their sources)  Overlap Looking at each cancer, there is a good amount of overlap between the genetic interactions and the a priori genes of interest.\n   Cancer num. genes     COAD 108   LUAD 218   MM 15   PAAD 295    To see these genes in relation to each other, I imported the STRING pathway and selected just the proteins found in the overlap.\nThe STRING data base was downloaded on 2019-09-20 and all the original files are in my data base directory \u0026ldquo;/n/no_backup2/dbmi/park/jc604/databases/networks/STRING/\u0026ldquo;. The preparation was done in \u0026ldquo;munge/40_STRING-network-preparation.R\u0026rdquo;.\nDuring this analysis, I decided to stop because the computation was taking too long and the output was unlikely to be interesting. I will revisit this analysis, but I first want to deal with the zoomed-out view of comparing the results of the alleles.\nHigh-level genetic interaction figures This analysis was conducted in \u0026ldquo;src/20_40_highlivel-genetic-interactions.R\u0026rdquo;.\nI began work on the genetic interaction figures with the Fisher\u0026rsquo;s exact test used for comutation and the RC-test used for mutual exclusivity. I employed UpSet plots (using UpSetR) to visualize the overlap of the comutation and mutual exclusive interactions. As Joe stated, the UpSet plot is essentially a higher-dimensional Venn diagram.\n(The following plots do not have titles because there is no parameter for adding one in UpSetR\u0026hellip;)\nCOAD Comutation\nMutually Exclusive\nLUAD Comutation\nMutually Exclusive\nMM Comutation\nMutually Exclusive\nPAAD Comutation\nMutually Exclusive\nI also re-created the genetic interaction network plots. This time, however, I did not include the names all of genes, but instead use the plot to demonstrate higher-level trends.\nCOAD Many of the alleles are connected by shared mutually-exclusive interactions and have their own \u0026ldquo;clouds\u0026rdquo; of comutation interactions. This can be seen very clearly between G12D and G12V.\nInterestingly, Q61K and Q61L seem to be quite similar.\nLUAD There is a lot of overlap of mutually exclusive interactions between G12C and G12V. These alleles are both driven by smoke, but I can\u0026rsquo;t think of an explanation why this would drive mutual exclusivity.\nMM The allele-specific genetic interactions are very sparse, possibly speaking to the large distribution of KRAS alleles found in the diease. This may indicate that the allele is not as impactful in MM as it is in COAD, LUAD, and PAAD.\nThere are a few mutually exclusive partners shared by a few alleles.\nPAAD There are a lot of significant interactions here. Interestingly (worryingly?) I report here many(!) more comutation interactions than GM does in his figure even though we are use the same results. Even if I reduce the p-value cutoff to 0.01, I report at least an order of magnitude more interactions that GM. I definitely need to get to the bottom of this\u0026hellip;\nFinal notes  I need to look into why there is such a large discrepancy between my and GM\u0026rsquo;s figures, especially for PAAD. It appears that there are some genes that comutate with one allele and are mutually exclusive with another. These may be interesting to look further into. Not all of the alleles are appearing in the UpSet plots. I have added a note to the code to fix this.  ","date":1570665600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570665600,"objectID":"5696a3ff02198fe382c1b93ddce94f02","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-10/","publishdate":"2019-10-10T00:00:00Z","relpermalink":"/post/2019-10-10/","section":"post","summary":"Comparing results from Fisher\u0026rsquo;s test and RC-test Looking at GM\u0026rsquo;s figure 3, I\u0026rsquo;m not sure how he has such a sparse figure for PAAD. From his results, there should be a lot of genes for KRAS G12D (\u0026gt; 800) at even a p-value cut-off of 0.01.\nFrom yesterday\u0026rsquo;s conclusion to use the Fisher\u0026rsquo;s exact test for comutation and the RC-test for mutual exclusivity, I created a combined data frame with both of these data for future use: genetic_interaction_df.","tags":[],"title":"2019-10-10","type":"post"},{"authors":[""],"categories":[],"content":" Synthetic Lethality Synthetic lethality refers to a genetic interaction whereby one mutation sensitizes an organism to another normally-benign mutation. This overlaps with \u0026ldquo;dependency\u0026rdquo; whereby the first mutation pushes the organism into a state of reliance on specific functions. Blocking (by mutation or inhibition) this function would cause the mutant organism to die, but not effect the wild-type organisms. Thus, much of current cancer therapy research is focused on finding synthetic lethal interactions with common oncogenes.\nAllele-specific synthetic lethality The goal of this portion of the Comutation project is to identify synthetic lethal interactions with specific KRAS alleles. From a theory point-of-view, these interactions would provide information on the differences between the alleles. From a therapeutics point-of-view, the identification of allele-specific interactions could be used to further personalize treatment strategies towards the pursuit of precision medicine.\nData For this analysis, we used the Cancer Dependency Mapping (DepMap) data. In this ongoing study, the cell lines from the Cancer Cell Line Encyclopedia (CCLE) were analyzed in a genome-wide, CRISPR-Cas9, loss-of-function screen whereby each gene was systemically knocked-out and the loss of growth of the cell line was measured. Thankfully, many omics data are available for the cell lines, including RNA expression, mutations, and CNA.\n(Of note, there was an RNAi screen, though it was not as extensive as the CRISPR screen, and thus, was not used for this analysis.)\nResults Identification synthetic lethal interactions The first test employed searched for individual genes with allele-specific synthetic lethality. Any depletion effects of knocking-out a gene that could be explained by the gene\u0026rsquo;s own RNA expression were removed first, as this was likely the cause. Then, an ANOVA was used to find genes that had differential effects across cell lines when grouped by their KRAS allele. The genes with a statistically significant (p \u0026lt; 0.01) difference are shown below. Below the heatmaps are specific genes with strong allele-specific effects.\nCOAD\nLUAD\nBecause there are too many genes to show their names for LUAD, I identified enriched functions in the clusters. The functions that are a single gene are either transcription factors or kinases with their targets enriched in the cluster (the number at the end of each bar indicates the cluster).\nPAAD\nFunctional enrichment of synthetic lethal interactions I use GSEA to identify functions that were generally enriched by KRAS allele. Select results are shown below, but the full results are available in the notebook page from 2019-10-18. Note that a positive NES corresponds to stronger depletion effect.\nG12V de-enriched for nonsense-mediated decay\nG12V enriched in TP53-regulated metabolism\nG13D de-enriched for complement\nG13D de-enriched for the ETC\nLUAD\nG12C enriched in the Bard1 pathway\nG12C enriched in the Faconi anemia pathway\nG12C de-enriched for $\\beta$ alanine metabolism\nPAAD\nG12R enriched in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1\nG12R enriched in NF-kB Signaling Pathway\nG12R enriched in G2/M DNA damage checkpoint\nG12V de-enriched in the hedgehog signaling pathway\nG12V de-enriched in the regulation of cholesterol biosynthesis by SREBP (SREBF)\nNo obvious differences in the general distribution of depletion effects per allele Of note, there are no obvious differences in the overall distribution of depletion effects per KRAS allele.\n","date":1570618710,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570618710,"objectID":"7b062ec3f65d8e9795bb59850a7c7902","permalink":"https://project-notebook-comutation.netlify.com/project/allele-specific-synthetic-lethality/","publishdate":"2019-10-09T06:58:30-04:00","relpermalink":"/project/allele-specific-synthetic-lethality/","section":"project","summary":"Synthetic Lethality Synthetic lethality refers to a genetic interaction whereby one mutation sensitizes an organism to another normally-benign mutation. This overlaps with \u0026ldquo;dependency\u0026rdquo; whereby the first mutation pushes the organism into a state of reliance on specific functions. Blocking (by mutation or inhibition) this function would cause the mutant organism to die, but not effect the wild-type organisms. Thus, much of current cancer therapy research is focused on finding synthetic lethal interactions with common oncogenes.","tags":["synthetic lethality","KRAS"],"title":"KRAS Allele-Specific Synthetic Lethality","type":"project"},{"authors":[""],"categories":[],"content":" Overview Our hypothesis is that genes with comutate or be mutually exclusive with specific KRAS alleles depending on the biological properties of the allele. Comutation would occur when the additional mutation enhances the growth phenotype of the tumor. And example of this would be KRAS, TP53, and CDKN2A in PAAD. On the other hand, another gene and KRAS would mutate in a mutually exclusive pattern because doing so leads to a reduction in growth. A very strong example of this is the mutually exclusive activation mutations in BRAF and KRAS.\nAnalysis Comutation To study comutation, we conducted a one-sided Fisher\u0026rsquo;s exact test for association between each KRAS allele and all other genes.\nMutual Exclusivity The Row-Column test for mutual exclusivity (the \u0026ldquo;RC-test\u0026rdquo;) was developed by the Raphael Lab in 2016 and described in A weighted exact test for mutually exclusive mutations in cancer (Leiserson et al., 2016). The software supplied with the paper searched for any groups of genes demonstrating mutually exclusive relationships, but took far too long to compute over all of our samples. Therefore, I implemented the RC-test in my own R package (in dev, WeXT) and used Snakemake to orchestrate the runs on O2 in parallel. Again, the test was run between each KRAS allele and all other genes.\nHigh-level visualization To provide a higher-level visualization of the results, the genetic interactions were displayed as a network. These are meant to be interpreted as \u0026ldquo;clouds\u0026rdquo; where the density of the cloud provides an idea of the number of interactions.\nI also created UpSet plots to show the size and overlap of the sets. These can be interpreted as high-dimensional Venn diagrams.\nAnalysis of biological properties of the genetic interactors I used a priori gene lists to identify any genes of interest that have detectable genetic interactions with the KRAS alleles. The lists were notable KEGG pathways, the physical interactors of KRAS from a BioID experiment conducted in Kovalski et al., 2019, and the COSMIC Cancer Gene Consensus.\nI also used Enrichr (Chen et al., 2013) to identify gene sets enriched in the interactors for each KRAS allele.\nResults The following figure shows the number of genes with a genetic interaction that was detected for each KRAS allele. For comutation, there had to be at least 3 comutation events to be included. For mutual exclusivity, the other gene had to be mutated at least 10 times in the cancer. For both tests, a p-value of 0.01 was used for the declaration of statistical significance.\nThe plot shows that the number of detectable interactions increases with the number of samples, as expected.\nThe plot below shows the distribution of number of mutually exclusive events by p-value of the association.\nThe rest of the summary is subdivided by cancer.\nCOAD\nLUAD\nMM\nPAAD\nCOAD Below are the high-level visualizations of the genetic interactions. The alleles tend to be connected by mutual exclusive interactions (instead of comutation interactions). Each allele also has their own set of comutation and mutually exclusive interactors.\nThe network below shows all of the interactions with genes in the a priori lists. As expected, BRAF is strongly mutually exclusive with many of the alleles and PIK3CA and APC comutate with several alleles, too. Surprisingly, G12D and G13D are mutually exclusive with TP53. A146T has two interesting comutation interactions with PORCN and MAP3K1. G12V has a very strong comutation interaction with SMAD4. G12C has a strong comutation interaction with RAPGEF2. G12S (bottom left) has a comutation interaction with SMAD3.\nThe KEGG pathway gene set was very informative. Notably, G13D was enriched for the mTOR pathway, including RICTOR as shown in the above network. The genes with interactions with G12D are enriched in adhesion pathways (\u0026ldquo;Regulation of actin cytoskeleton\u0026rdquo; and \u0026ldquo;Focal adhesion\u0026rdquo;, \u0026ldquo;Leukocyte TEM\u0026rdquo;), possibly linked to the enrichment for the Rap1 signaling pathway. Many of the alleles have interactions with genes involved in ERBB signaling.\nAlso of note, but not shown graphically here, the physical interactors of SMAD2, a transcription factor, were found to be enriched in the G12D genetic interactors by two different gene sets.\nA more direct visualization of the mutually exclusive and comutation interactions is via an oncoplot. On a heatmap, it shows a sample per column and a gene per row. The cell is filled with a color if the sample is mutated in the gene. The arrangement of the samples highlights the genetic interactions by showing either the overlap or exclusivity.\nI have shown them here for a select few of the alleles with interesting interactions. For the paper, a more selective portion of the interactions will be shown.\nLUAD Below are the high-level visualizations of the genetic interactions. The alleles tend to be connected by mutual exclusive interactions (instead of comutation interactions). This is especially true for G12C, G12V, and G12D. Each allele also has their own set of comutation and mutually exclusive interactors. There are many genes that are mutually exclusive with one allele and comutate with another.\nThe genetic interaction networks with genes in the a prior lists are divided in to the KEGG pathways (top) and the CGC (bottom). There are very strong mutually exclusive relationships between EGFR, BRAF, and TP53, as expected. Also, there is a strong comutation interaction between G12C and STK11. In the CGC network, it appears that G12C is mutually exclusive with CTNNB1 ($\\beta$-catenin). G12C also is mutually exclusive with three different genes involved in voltage-gated calcium channels. G12C is mutually exclusive with JAG2 and comutates with NOTCH1 suggesting a special relationship with the Notch signaling pathway. The three alleles linked to the smoking mutational signature, G12A/C/V, and Q61L have strong comutation interactions with ATM. There are several comutation interactions that are unexpected, namely between G12D and G12R with NKX2-1, Homeobox protein Nkx-2.1. This gene is a \u0026ldquo;transcription factor that binds and activates the promoter of thyroid specific genes,\u0026rdquo; and \u0026ldquo;may play a role in lung development and surfactant homeostasis,\u0026rdquo; (UniProt P43699). Another interesting relationship is that KRAP1 comutates with G13D and G13C, but is mutually exclusive with G12V and G12C. This could indicate an codon-specific property of hyperactivated KRAS in LUAD.\nThe results of an enrichment analysis using a gene set of PPI hub proteins are shown first. The physical interactors with $\\beta$-catenin and SMARC4 are enriched in the interactors of G12C. The interactors of PKC-$\\alpha$ (gene PKRCA) are enriched in G12V genetic interactions. PKC-$\\alpha$ is a \u0026ldquo;calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, tumorigenesis, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascade involving MAPK1/3 (ERK1/2) and RAP1GAP,\u0026rdquo; (UniProt P17252).\nThe results of an enrichment analysis using a gene set of GO Biological Processes are shown below. G12A seems to have an enrichment for genes involved in P53-mediated cell cycle arrest. There are several Ras-related processes enriched in the G12C interactors.\nBelow are the oncoplots for the more common alleles in LUAD.\nMM Below are the high-level visualizations of the genetic interactions. There were not very many hits for multiple myeloma and very little overlap of the interacting genes between KRAS alleles.\nBelow is the network of genetic interactions for genes in the a priori lists. There is a detectable mutually exclusive interaction between Q61H and BRAF, though it is documented that MM can be highly multi-clonal. Therefore, there are often subpopulations of KRAS mutants and BRAF mutants within a single disease. This is likely true for KRAS and other genes, making the interpretation of these results difficult.\nThere was little evidence for functional enrichment in these genes.\nPAAD Below are the high-level visualizations of the genetic interactions. There were many allele-specific comutation and mutually exclusive interactions detected in PAAD. Further or more strict thresholds may be applied in future analyses to reduce false-positives.\nBelow are the interaction networks for genes in the a priori gene lists.\nThe first is of genes found to directly interact with KRAS in the CGC. Along with BRAF, there were some unexpected genes found to be mutually exclusive with multiple alleles. Interestingly, RNF43 was foound to be mutually exclusive with G12R, but comutates with G12D. RNF43 is \u0026ldquo;E3 ubiquitin-protein ligase that acts as a negative regulator of the Wnt signaling pathway by mediating the \u0026hellip; degradation of \u0026hellip; Frizzled,\u0026rdquo; (UniProt Q68DV7). In addition, TP53 is mutually exclusive with G12V, but comutates with Q61H and G12D. This is interesting because of the general perception that both KRAS and TP53 mutations are quintessential steps of PAAD progression. SMARCA4 is strongly mutually exclusive with G12R.\nThe following is the network of genetic interactions with genes found to directly interact with KRAS. One of the strongest interactions is between G12V and ATP2B1, the protein product of which helps regulate intracellular calcium levels at the plasma membrane. Another strong interaction is the mutually exclusive relationship between G12D and NF1. The obvious mechanism to propose for this is the same as that for BRAF.\nThe next genetic network is of the genes from select KEGG pathways. An interaction that really pops out is the strong comutation between Q61K and MAP3K13 and compared to the mutually exclusive relationships between G12V and G12R and the same gene. A similar case of conflicting interactions is found with MAP2K4 where it comutates with Q61R and is mutually exclusive with G12D. G12D strongly comutates with TGFBR2 - this transmembrane S/T-kinase activates SMAD2/4 when it binds with the cytokines TGFB1/2/3 (UniProt P37173). JAG2 is found to comutate with G12R, yet is mutually exclusive with G12V.\nTwo gene sets with interesting results from the enrichment analysis are shown below. The top is of kinases whose substrates are overrepresented in the associations, and the bottom is of Panther pathways.\nThere are a lot of substrates for the kinase PKA C-$\\alpha$ (gene PRKACA) that have genetic interactions with G12D and G12V. This kinase is involved in many cellular functions including Hedgehog and NF$\\kappa$B signaling. The substrates of Akt1 are also overrepresented in the genes with genetic interactions with G12D.\nMany genes involved in Wnt signaling have genetic interactions with several alleles. Genes of the EGFR pathway have many interactions with G12D.\nBelow are the oncoplots for the more interesting alleles in PAAD.\n","date":1570618689,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570618689,"objectID":"696696eb53b5eb218f5299cab72e8b92","permalink":"https://project-notebook-comutation.netlify.com/project/comutation-and-mutual-exclusivity/","publishdate":"2019-10-09T06:58:09-04:00","relpermalink":"/project/comutation-and-mutual-exclusivity/","section":"project","summary":"Testing for genetic interactions in human tumor samples based on their mutational patterns.","tags":["comutation","KRAS"],"title":"Comutation and Mutual Exclusivity","type":"project"},{"authors":[],"categories":[],"content":" Finish preparing RC-test results The final step was to merge the actual mutation numbers for each gene to the results from the RC-test.\nThese new values were used to update the plots made in \u0026ldquo;20_30_rc-test-results-analysis.R\u0026rdquo; (also shown in the notebook for 2019-10-07).\nGeneral scope of results Below is the number of significant interactions (p-value \u0026lt; 0.05 and at-least 3 events) per cancer found by the RC-test.\nThe plot below separates the bars by the type of interaction.\nInteraction networks Munge Fisher\u0026rsquo;s test for comutation results To compare against the RC test, I prepared the results from GM\u0026rsquo;s test for comutation (a Fisher\u0026rsquo;s exact test). The file \u0026ldquo;OR_fisher_multiTest_Aug2019.txt\u0026rdquo; was copied from the shared DropBox to \u0026ldquo;data/fisher-comutation\u0026rdquo;. It is prepared for further use in \u0026ldquo;munge/35_comutation-results-gm.R\u0026rdquo;.\nFor future reference, here is the 2x2 table that GM used for the columns n00 through n11:\n     KRAS        WT mut   gene WT n00 n01    mut n10 n11    Comparing results from Fisher\u0026rsquo;s test and RC-test This comparison was conducted in \u0026ldquo;src/20_35_rc-fisher-comparison.R\u0026rdquo;.\nThe first plot just shows the gross number of genes found to be signficant for each test, split by comutation and mutual exclusivity.\nThis plot shows a large discrepancy between the two tests: the RC-test was more sensitive when testing for mutual exclusivity while the opposite was true for the Fisher\u0026rsquo;s exact test. On closer inspection, it seemed that the Fisher\u0026rsquo;s test out-performed the RC-test for detecting comutation because we were able to use the panel data. The panel data could not be used for the RC-test because the test accounts for the total number of mutations in the sample.\nFrom these results, I propose that we use the Fisher\u0026rsquo;s test for comutation and RC-test for mutual exclusivity. This makes sense in so far as the RC-test was originally made for detecting mutual exclusivity and is equivalent (when comparing two genes) to the Fisher\u0026rsquo;s exact test for comutation as it approaches the limit. Therefore, it is an approximation where it is not needed because we can just do the Fisher\u0026rsquo;s exact test.\n","date":1570579200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570579200,"objectID":"27c3960d547db1a919c17442340ca601","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-09/","publishdate":"2019-10-09T00:00:00Z","relpermalink":"/post/2019-10-09/","section":"post","summary":"Finish preparing RC-test results The final step was to merge the actual mutation numbers for each gene to the results from the RC-test.\nThese new values were used to update the plots made in \u0026ldquo;20_30_rc-test-results-analysis.R\u0026rdquo; (also shown in the notebook for 2019-10-07).\nGeneral scope of results Below is the number of significant interactions (p-value \u0026lt; 0.05 and at-least 3 events) per cancer found by the RC-test.\nThe plot below separates the bars by the type of interaction.","tags":[],"title":"2019-10-09","type":"post"},{"authors":[],"categories":[],"content":" Plan for analysis I did not have time to work on this project today, but I found time in the evening to think about how I want to progress.\nRC-test results analysis Tomorrow, I will focus on moving forward with analyzing the results from the RC-test. I need to merge in the number of mutation events in order to remove the genetic interactions that do not meet a low standard. For comutation, there should be at least 2 co-mutation events. For mutual exclusivity, the other gene should be mutated in at least 0.01% of all the cancer\u0026rsquo;s samples. This will remove a lot of mutually exclusive events that are caused by the mutation just being very rare.\nI will then compare the results to those from the Fisher\u0026rsquo;s exact test:\n How many genes are shared by each allele between the two analyses (Venn diagram for each allele) For the shared genes, how do the p-values compare (scatter plot with x and y-axis as p-value from each analysis; a line for $y = x$)  Finally, I will look for interesting results in the significant genes. This will start with highlight CGC genes. Also those found from the BioID screen of KRAS and KRAS mutants. Lastly, I will use WebGestalt, EnrichR, or PANTHER (PMID: 23868073 for updated overview) to find functional patterns in the gene lists.\nFor the paper, I see the text reading something to the effect of, \u0026ldquo;X tended to comutate with KRAS A and B but no interaction was detected for KRAS C nor D,\u0026rdquo; for individual CGC genes. Also, for any enriched biological processes, the text would look something like, \u0026ldquo;There was an enrichment for function Y in the genes found to comutate with KRAS E, potentially suggesting \u0026hellip;\u0026rdquo;\nHere is where I will stop until completing the synthetic lethal analysis. Once I have completed that to a satisfactory degree, I will look for overlap between the hits from each analysis.\nAllele-specific synthetic lethality So far, I have only completed the simplest possible analysis to find allele-specific synthetic lethality. Briefly, I removed the genes that could be explained by their RNA expression. Then, I conducted an ANOVA and pair-wise comparisons to find differences in lethality between cells with the various KRAS alleles, including WT. Some of the most interesting results can be found on yesterday\u0026rsquo;s notebook, and all plots are available in \u0026ldquo;graphs/10_10_linear-modeling-syn-let_bosplots/\u0026ldquo;.\nI want a way of visualizing all of these results (especially for the meeting with KH and PJP). The obvious way is to produce a heatmap of patient vs. gene with the genes that were found to have a significant difference. Then, I could show specific box-plots for genes of interest (CGC, KRAS interactors from BioID screen, specific KEGG pathways).\nAnother approach could be to look for enriched biological processes/pathways. To this end, we could employ an analysis similar to GSEA. We could run GSEA as one KRAS allele against all other cell lines or just the KRAS WT cell lines. I will also look into GSVA and ssGSEA, two popular variants of GSEA.\nA quick analysis that could be very fruitful is to conduct a PCA on the gene-space and see if the cell lines cluster by KRAS allele. If they do, that would lend credence to our claim that the KRAS allele is important. (It may be useful to plot the first few PCs using tSNE or UMAP.) If there appear to be clusters, then some sort of clustering (K-means, hierarchical clustering, DBSCAN, spectral clustering, etc.) could be used to make the claim concrete. Even just a difference between KRAS and WT would be supportive of our claim.\nLASSO of KRAS WT vs mutant starting with all genes as covariates. Use the genes with non-trivial parameters in a random forest classifier or niave bayes classifier to predict the KRAS allele (including WT).\n","date":1570492800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570492800,"objectID":"2baef37321172e099be496affdf38b48","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-08/","publishdate":"2019-10-08T00:00:00Z","relpermalink":"/post/2019-10-08/","section":"post","summary":"Plan for analysis I did not have time to work on this project today, but I found time in the evening to think about how I want to progress.\nRC-test results analysis Tomorrow, I will focus on moving forward with analyzing the results from the RC-test. I need to merge in the number of mutation events in order to remove the genetic interactions that do not meet a low standard.","tags":[],"title":"2019-10-08","type":"post"},{"authors":[],"categories":[],"content":" RC Co-mutation test Introduction A while back, I thought of using the RC-test for co-mutation and mutual exclusivity from A weighted exact test for mutually exclusive mutations in cancer (Leiserson et al., 2016) in place of the Fisher\u0026rsquo;s exact test that Giorgio had employed. The benefit of this test is that it accounts for the number of mutations per sample in its estimate of significance. The main draw back is that it is permutation-based, and thus very slow.\nI was able to write a Snakemake script to run the test for all cancers and KRAS alleles. It has finally completed all of the tests and I will now port it over to this project. To move forward with the analysis, I will just port over the results and begin parsing. I will go back and move the files for running the analysis over in the future. For now, it is located on O2 at the following URL: \u0026ldquo;/n/data2/bidmc/medicine/haigis/Cook/KrasComutation/FinalAnalyses/RC_comutation_2/\u0026rdquo;\nMunging I copied the directory of the output of the RC-test into the data dir.\nmkdir data/rc-test-results cp -r ../KrasComutation/FinalAnalyses/RC_comutation_2/output/* data/rc-test-results  These files are automatically loaded into R by running load.project(). I combined all of the information into a single data frame, rc_test_results, in the munging script \u0026ldquo;30_rc-test_results-prep.R\u0026rdquo;. Here, I also extracted the non-KRAS gene from the gene_set column. The raw files were added to the list of raw data to ignore in \u0026ldquo;config/global.dcf\u0026rdquo;.\nAnalyzing RC-test results General scope of results Below is the number of significant interactions (p-value \u0026lt; 0.05 and at-least 3 events) per cancer found by the RC-test.\nThe plot below separates the bars by the type of interaction.\nInteraction networks Moving the RC-test directory to this project I got this far and decided that moving forward with any analysis would require a lot of the information from the RC-test directory. Therefore, I stopped and ported it over. The following are the steps I took.\nMoving input, intermediate, and output data mkdir data/rc-test mkdir data/rc-test/input data/rc-test/intermediate data/rc-test/output  cp ../KrasComutation/FinalAnalyses/RC_comutation_2/input/* data/rc-test/input/ cp ../KrasComutation/FinalAnalyses/RC_comutation_2/intermediate/* data/rc-test/intermediate/ cp -r ../KrasComutation/FinalAnalyses/RC_comutation_2/output/* data/rc-test/output/ cp -r ../KrasComutation/FinalAnalyses/RC_comutation_2/permuted_graphs data/rc-test/  Moving example DAG image cp ../KrasComutation/FinalAnalyses/RC_comutation_2/images/dag.pdf graphs/20_20_rc-test_Snakefile/  Moving scripts cp ../KrasComutation/FinalAnalyses/RC_comutation_2/Snakefile src/20_20_rc-test_Snakefile cp ../KrasComutation/FinalAnalyses/RC_comutation_2/snakemake_scripts/* src/ cp ../KrasComutation/FinalAnalyses/RC_comutation_2/prepare_input_tables.R src/ cp ../KrasComutation/FinalAnalyses/RC_comutation_2/generate_sm_output_names.R src cp ../KrasComutation/FinalAnalyses/RC_comutation_2/cluster.json config/  The snakemake scripts were renamed. I did my best to update the Snakefile for the new directory, but real testing will be required to truly find out. A bash script was created to run the Snakemake file on O2, \u0026ldquo;20_21_run-rc-test-snakemake.sh\u0026rdquo;.\nMunging cancer data from Giorgio Melloni GM used a deeply-nested data structure for the cancer data. His format is not conducive to my coding style (and is very large). I created another munging script to prepare this data, \u0026ldquo;20_prepare-cancer-data.R\u0026rdquo;. The files from GM were copied from the old directory to \u0026ldquo;data/cancer-data/\u0026rdquo;.\n","date":1570406400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570406400,"objectID":"6a36a2edc754968882819e9fb2e4d5a0","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-07/","publishdate":"2019-10-07T00:00:00Z","relpermalink":"/post/2019-10-07/","section":"post","summary":"RC Co-mutation test Introduction A while back, I thought of using the RC-test for co-mutation and mutual exclusivity from A weighted exact test for mutually exclusive mutations in cancer (Leiserson et al., 2016) in place of the Fisher\u0026rsquo;s exact test that Giorgio had employed. The benefit of this test is that it accounts for the number of mutations per sample in its estimate of significance. The main draw back is that it is permutation-based, and thus very slow.","tags":[],"title":"2019-10-07","type":"post"},{"authors":[],"categories":[],"content":" Modeling KRAS allele-specific synthetic lethality (cont.) Continuing from yesterday, I worked on plotting the box-plots of genes found to be significantly depleted in KRAS mutants. There was a bug in \u0026lsquo;ggpubr\u0026rsquo; that installing the dev. version from GitHub fixed. I also ignored cell lines of LUAD with KRAS G13D mutations because they are irrelevant to patients.\nDepletion box-plots were made for the genes that passed the following criteria:\n The linear model of depletion effect and RNA expression was non-significant (p-value \u0026lt; 0.01). The ANOVA across all alleles was significant at a relatively stringent cut-off (p-value \u0026lt; 0.01). There was at least one significant pairwise comparison (FDR adj. p-value \u0026lt; 0.05)  All of the box-plots are in \u0026ldquo;graphs/10_10_linear-modeling-syn-let_boxplots/\u0026ldquo;. Below are some of the more interesting genes to pop out of the analysis.\nCOAD From UniProt ARI5B_HUMAN:\n Transcription coactivator that binds to the 5\u0026rsquo;-AATA[CT]-3\u0026rsquo; core sequence and plays a key role in adipogenesis and liver development. Acts by forming a complex with phosphorylated PHF2, which mediates demethylation at Lys-336, leading to target the PHF2-ARID5B complex to target promoters, where PHF2 mediates demethylation of dimethylated \u0026lsquo;Lys-9\u0026rsquo; of histone H3 (H3K9me2), followed by transcription activation of target genes\u0026hellip; Required for adipogenesis: regulates triglyceride metabolism in adipocytes by regulating expression of adipogenic genes. Overexpression leads to induction of smooth muscle marker genes, suggesting that it may also act as a regulator of smooth muscle cell differentiation and proliferation.\n From UniProt SRP09_HUMAN:\n Signal-recognition-particle assembly has a crucial role in targeting secretory proteins to the rough endoplasmic reticulum membrane. SRP9 together with SRP14 and the Alu portion of the SRP RNA, constitutes the elongation arrest domain of SRP. The complex of SRP9 and SRP14 is required for SRP RNA binding.\n LUAD From UniProt: STABP_HUMAN:\n Zinc metalloprotease that specifically cleaves \u0026lsquo;Lys-63\u0026rsquo;-linked polyubiquitin chains. Does not cleave \u0026lsquo;Lys-48\u0026rsquo;-linked polyubiquitin chains (By similarity). Plays a role in signal transduction for cell growth and MYC induction mediated by IL-2 and GM-CSF. Potentiates BMP (bone morphogenetic protein) signaling by antagonizing the inhibitory action of SMAD6 and SMAD7. Has a key role in regulation of cell surface receptor-mediated endocytosis and ubiquitin-dependent sorting of receptors to lysosomes. Endosomal localization of STAMBP is required for efficient EGFR degradation but not for its internalization (By similarity). Involved in the negative regulation of PI3K-AKT-mTOR and RAS-MAP signaling pathways.\n PAAD From UniProt: EGLN2_HUMAN:\n Cellular oxygen sensor that catalyzes, under normoxic conditions, the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. Hydroxylates a specific proline found in each of the oxygen-dependent degradation (ODD) domains (N-terminal, NODD, and C-terminal, CODD) of HIF1A. Also hydroxylates HIF2A\u0026hellip; Hydroxylated HIFs are then targeted for proteasomal degradation via the von Hippel-Lindau ubiquitination complex. Under hypoxic conditions, the hydroxylation reaction is attenuated allowing HIFs to escape degradation resulting in their translocation to the nucleus, heterodimerization with HIF1B, and increased expression of hypoxy-inducible genes. EGLN2 is involved in regulating hypoxia tolerance and apoptosis in cardiac and skeletal muscle. Also regulates susceptibility to normoxic oxidative neuronal death. Links oxygen sensing to cell cycle and primary cilia formation by hydroxylating the critical centrosome component CEP192 which promotes its ubiquitination and subsequent proteasomal degradation. Hydroxylates IKBKB, mediating NF-kappaB activation in hypoxic conditions. Target proteins are preferentially recognized via a LXXLAP motif.\n From UniProt JUN_HUMAN:\n Transcription factor that recognizes and binds to the enhancer heptamer motif 5\u0026rsquo;-TGA[CG]TCA-3\u0026rsquo; (PubMed:10995748, PubMed:22083952). Promotes activity of NR5A1 when phosphorylated by HIPK3 leading to increased steroidogenic gene expression upon cAMP signaling pathway stimulation (PubMed:17210646). Involved in activated KRAS-mediated transcriptional activation of USP28 in colorectal cancer (CRC) cells (PubMed:24623306). Binds to the USP28 promoter in colorectal cancer (CRC) cells (PubMed:24623306).\n Notes for tomorrow There were some genes that have way too many data points (see example below). I need to figure out what is causing this. My guess is that they are related genes and the gene names are being truncated by get_hugo_from_depmap_ids().\n","date":1570233600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570233600,"objectID":"ea7875c62cda805f9bc86ce095e301be","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-05/","publishdate":"2019-10-05T00:00:00Z","relpermalink":"/post/2019-10-05/","section":"post","summary":"Modeling KRAS allele-specific synthetic lethality (cont.) Continuing from yesterday, I worked on plotting the box-plots of genes found to be significantly depleted in KRAS mutants. There was a bug in \u0026lsquo;ggpubr\u0026rsquo; that installing the dev. version from GitHub fixed. I also ignored cell lines of LUAD with KRAS G13D mutations because they are irrelevant to patients.\nDepletion box-plots were made for the genes that passed the following criteria:\n The linear model of depletion effect and RNA expression was non-significant (p-value \u0026lt; 0.","tags":[],"title":"2019-10-05","type":"post"},{"authors":[],"categories":[],"content":" I have outlined an estimate for a time-line for the rest of the project to the first submission. It is located on the homepage of this website.\nModeling KRAS allele-specific synthetic lethality I began by trying to use a linear model, regressing on KRAS allele, RNA expression of the tarter, and whether the target was altered (CN amplification or coding mutation). I then used a step-wise AIC feature selection method to optimize the model for each gene. I ran into a problem, however, in how to declare the intercept of the model. Originally, I had the WT allele set as the intercept, but this is irrelevant for the RNA expression feature. To further complicate matters, PAAD does not have enough WT KRAS cell lines, so the intercept was set to KRAS G12D. This is obviously not what we want to model\nTherefore, I have changed to a two-step process. First, I regress the depletion effect on the RNA expression of the target gene. The genes with a significant model (p \u0026lt; 0.01) are discorded. The second step is to run an ANOVA and conduct pair-wise T-tests.\nProblem: While doing this, I realized that LUAD only has enough cell lines (at least 3) for WT and G12C, but not G12V like there was before. I found that the problem was I specifically selected cell lines by their disease subtype containing \u0026ldquo;Adenocarcinoma\u0026rdquo;. I changed the selection criteria for the lung cell lines to linear_subtype == \u0026quot;lung_NSC\u0026quot;. The problem was resolved.\n","date":1570147200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570147200,"objectID":"4ac960d960edd24c502df0820a02f646","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-04/","publishdate":"2019-10-04T00:00:00Z","relpermalink":"/post/2019-10-04/","section":"post","summary":"I have outlined an estimate for a time-line for the rest of the project to the first submission. It is located on the homepage of this website.\nModeling KRAS allele-specific synthetic lethality I began by trying to use a linear model, regressing on KRAS allele, RNA expression of the tarter, and whether the target was altered (CN amplification or coding mutation). I then used a step-wise AIC feature selection method to optimize the model for each gene.","tags":[],"title":"2019-10-04","type":"post"},{"authors":[],"categories":[],"content":" Analysis to remove genes that can confidently be removed (cont.) I finished up making confidently_unexpressed_genes (cached). I then returned to the munging script for preparing the model data and removed the genes were are confident are not expressed in the normal or tumor.\nLinear modeling allele-specificity Linear Model 1 The first model I tried was a simple linear model (using lm()) of the following form.\ngene_effect ~ allele + is_altered + rna_scaled  It attempts the use the KRAS allele, A step-wise feature selection AIC-based method was applied to each model.\nOther thoughts\nLatent variable analysis of DepMap data. Regress on the depletion effect of each gene for a patient. The latent variables are signaling pathway. Results show which pathways are most important. But will I just pull out the essential pathways? The goal of the DepMap analysis is to find lethals.\nSo instead for each gene, have features be mutational status, RNA expression, CNA of other genes (each feature of each gene linked to each other). Latent variables are pathways.\n","date":1570060800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570060800,"objectID":"a3d4fa2b5190c664162009a18319708a","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-03/","publishdate":"2019-10-03T00:00:00Z","relpermalink":"/post/2019-10-03/","section":"post","summary":"Analysis to remove genes that can confidently be removed (cont.) I finished up making confidently_unexpressed_genes (cached). I then returned to the munging script for preparing the model data and removed the genes were are confident are not expressed in the normal or tumor.\nLinear modeling allele-specificity Linear Model 1 The first model I tried was a simple linear model (using lm()) of the following form.\ngene_effect ~ allele + is_altered + rna_scaled  It attempts the use the KRAS allele, A step-wise feature selection AIC-based method was applied to each model.","tags":[],"title":"2019-10-03","type":"post"},{"authors":[],"categories":[],"content":" Analysis to remove genes that can confidently be removed This was originally done in the old analysis structure, so can mainly be copied over to this directory system.\nThe HPA and GTEx data were moved from \u0026ldquo;/n/no_backup2/dbmi/park/jc604/databases/tissue_gene_expression/\u0026rdquo; to \u0026ldquo;data/tissue-gene-expression/\u0026rdquo;.\nA new munging script, \u0026ldquo;7_tissue-specific-genes.R\u0026rdquo;, was created and contained the same data preparation steps.\nThe raw data tables were put on the ignore list because:\n they have a header that must be skipped they are not used for any other analysis  The TCGA and MMRF gene expression data was also moved to \u0026ldquo;data\u0026rdquo; in a subdirectory called \u0026ldquo;data/tcga/\u0026rdquo;. This was added to the ignore list for data.\nThe munging begins by organizing the GTEx, HPA, and TCGA data. The MMRF data uses Ensembl gene IDs, so org.Hs.eg.db from Bioconductor was used to get the mappings to Hugo symbols. The following was run to create a data frame mapping the Ensembl gene IDs to their Hugo symbols. It is not included in a munging script because I do not want all of the horrible Bioconductor nonsense in my Namespace.\ncache(\u0026quot;gene_name_tib\u0026quot;, { suppressPackageStartupMessages(library(org.Hs.eg.db)) gene_name_tib \u0026lt;- full_join( as_tibble(as.data.frame(org.Hs.egENSEMBL)), as_tibble(as.data.frame(org.Hs.egSYMBOL)), by = \u0026quot;gene_id\u0026quot; ) %\u0026gt;% dplyr::select(-gene_id) %\u0026gt;% filter(!is.na(ensembl_id) \u0026amp; !is.na(symbol)) return(gene_name_tib) }) gene_name_tib #\u0026gt; # A tibble: 30,903 x 2 #\u0026gt; ensembl_id symbol #\u0026gt; \u0026lt;chr\u0026gt; \u0026lt;chr\u0026gt; #\u0026gt; 1 ENSG00000121410 A1BG #\u0026gt; 2 ENSG00000175899 A2M #\u0026gt; 3 ENSG00000256069 A2MP1 #\u0026gt; 4 ENSG00000171428 NAT1 #\u0026gt; 5 ENSG00000156006 NAT2 #\u0026gt; 6 ENSG00000196136 SERPINA3 #\u0026gt; 7 ENSG00000114771 AADAC #\u0026gt; 8 ENSG00000127837 AAMP #\u0026gt; 9 ENSG00000129673 AANAT #\u0026gt; 10 ENSG00000090861 AARS #\u0026gt; #  with 30,893 more rows  TODO  I need to finish make the list of genes to ignore for each caner cache this list do some plotting of the genes  ","date":1569974400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1569974400,"objectID":"0a181aa613488daf123a69240fc5cb61","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-02/","publishdate":"2019-10-02T00:00:00Z","relpermalink":"/post/2019-10-02/","section":"post","summary":"Analysis to remove genes that can confidently be removed This was originally done in the old analysis structure, so can mainly be copied over to this directory system.\nThe HPA and GTEx data were moved from \u0026ldquo;/n/no_backup2/dbmi/park/jc604/databases/tissue_gene_expression/\u0026rdquo; to \u0026ldquo;data/tissue-gene-expression/\u0026rdquo;.\nA new munging script, \u0026ldquo;7_tissue-specific-genes.R\u0026rdquo;, was created and contained the same data preparation steps.\nThe raw data tables were put on the ignore list because:\n they have a header that must be skipped they are not used for any other analysis  The TCGA and MMRF gene expression data was also moved to \u0026ldquo;data\u0026rdquo; in a subdirectory called \u0026ldquo;data/tcga/\u0026rdquo;.","tags":[],"title":"2019-10-02","type":"post"},{"authors":[],"categories":[],"content":" Munging DepMap 2019 Q3 release (cont.) Sample Info Information about all of the cell lines is available in \u0026ldquo;data/depmap19Q3/sample_info.csv\u0026rdquo;. I added a column \u0026quot;cancer\u0026quot; with the TCGA cancer names for each cell line; a NA value means it isn\u0026rsquo;t used in this project. I also joined kras_mutation_tib. Note, that this will duplicate any rows with multiple KRAS mutations.\nGene Effect This is the data for the effect of knocking out a gene. The tall-format tibble was saved to gene_effect.\nGene Dependency This is the data for the probability that a cell line is dependent upon the target gene. The tall-format tibble was saved to dependency_prob.\nRNAi KH has indicated some interest in using the RNAi experimental data, too.\nThe data was obtained from DepMap.\nwget -O data/depmap19Q3/D2_combined_gene_dep_scores.csv https://ndownloader.figshare.com/files/13515395  The tall-format tibble was saved to rnai_effect.\nPreparing data for modeling A new munging script was created to create the input data for the modeling of depletion effect by KRAS allele: \u0026ldquo;munge/15_depmap19Q3_model-data-prep.R\u0026rdquo;.\nThe first step was to identify the cell lines with multiple oncogenic KRAS mutations. They cannot be used for the analysis.\nCell lines with a BRAF V600E or oncogenic NRAS mutation will be removed, too.\nA base data frame was created for the modeling data. Only the cell lines for the relevant cancers were kept. It has the KRAS mutation information for each cell line and two columns for whether the gene is noted as essential or nonessential by DepMap (NA if neither). This data frame was cached as \u0026ldquo;model_data_base\u0026rdquo;.\nOnly alleles with at least 3 cell lines can be considered for this analysis. Another data frame was created to reflect this.\n734 genes for 3 cell lines were NA in the raw data. The cell lines were ACH-000118 (PAAD, KRAS G12R) ACH-000658 (MM, KRAS WT) ACH-001061 (COAD, KRAS WT). These data points were removed.\nNot all genes will be tested in the analysis because they do not exhibit a strong enough of a lethal effect. There were two criteria:\n a manual threshold of causing a depletion effect of -0.2 in at least two cell lines a metric based on a comparison of the scores in essential and non-essential genes  The threshold for the first criteria was two standard deviations above the mean of essential genes. The threshold for the second criteria was at the point where the distributions of the depletion effects of the essential and nonessential genes overlapped. By eye, these two cut-offs were fairly similar for each cancer. I should do an analysis of the effect of various cut-offs for the number of genes (added to TODO/Analyses/)\nRNA expression for each gene of each cell line was added as another column to the model data frame.\nAnother column was added to the model data frame called \u0026quot;is_altered\u0026quot;. It is true if there is a CNA or coding mutation in the cell line\u0026rsquo;s gene (else false).\nThis final data frame was saved as model_data_base where \u0026ldquo;base\u0026rdquo; denotes that it has all of the data to use for all of the models.\nAnother data frame was built from model_data_base that only has the data for KRAS alleles (including WT) that have at least 3 cell lines. This was cached as model_data.\nTODO I have forgotten to include the list of genes that can confidently be ignored from analysis for each cancer. I need to integrate these data in, too.\n","date":1569801600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1569844336,"objectID":"a061ab55829dff5ad52d57800500aa6f","permalink":"https://project-notebook-comutation.netlify.com/post/2019-09-30/","publishdate":"2019-09-30T00:00:00Z","relpermalink":"/post/2019-09-30/","section":"post","summary":"Munging DepMap 2019 Q3 release (cont.) Sample Info Information about all of the cell lines is available in \u0026ldquo;data/depmap19Q3/sample_info.csv\u0026rdquo;. I added a column \u0026quot;cancer\u0026quot; with the TCGA cancer names for each cell line; a NA value means it isn\u0026rsquo;t used in this project. I also joined kras_mutation_tib. Note, that this will duplicate any rows with multiple KRAS mutations.\nGene Effect This is the data for the effect of knocking out a gene.","tags":[],"title":"2019-09-30","type":"post"},{"authors":[],"categories":[],"content":" I am beginning the migration process from the only comutation directory to this project.\nDownloading DepMap 2019 Q3 release The first step is moving over the raw data into the new data directory. DepMap release 19Q3 data, so the new data sets were downloaded into \u0026ldquo;data/depmap19Q3/\u0026rdquo;\nwget -O Achilles_gene_effect.csv https://ndownloader.figshare.com/files/16757666 wget -O Achilles_gene_dependency.csv https://ndownloader.figshare.com/files/16757660 wget -O Achilles_guide_efficacy.csv https://ndownloader.figshare.com/files/16757669 wget -O Achilles_common_essentials.csv https://ndownloader.figshare.com/files/16757654 wget -O common_essentials.csv https://ndownloader.figshare.com/files/16757714 wget -O nonessentials.csv https://ndownloader.figshare.com/files/16757717 wget -O Achilles_guide_map.csv https://ndownloader.figshare.com/files/16757672 wget -O CCLE_expression.csv https://ndownloader.figshare.com/files/16757690 wget -O CCLE_gene_cn.csv https://ndownloader.figshare.com/files/16757699 wget -O CCLE_fusions.csv https://ndownloader.figshare.com/files/16757696 wget -O CCLE_mutations.csv https://ndownloader.figshare.com/files/16757702 wget -O sample_info.csv https://ndownloader.figshare.com/files/16757723  Munging DepMap 2019 Q3 release I then created the munging script called \u0026ldquo;10_depmap19Q3.R\u0026rdquo; to prepare the data downloaded from DepMap.\nEssentiality A single data frame was created for all of the data concerning whether a gene is labeled essential or non-essential. To help, I created get_huo_from_depmap_ids() and get_entrez_from_depmap_ids() to extract the appropriate names from the data tables. These functions are in \u0026ldquo;libs/helpers.R\u0026rdquo;. Tests were written in \u0026ldquo;tests/test-helpers.R\u0026rdquo;.\nCopy Number A data frame of CNA was created ccle_copy_number. According to the README from DepMap, the copy number values were \u0026ldquo;Gene level copy number data, log2 transformed with a pseudo count of 1.\u0026rdquo; However, looking at the values when converted back ($2^{x}$), I do not think there is a pseudo count because most of the values are 1 is there was. Therefore, I did not subtract 1 from the conversion. I also added a label for homozygous deletion (\u0026ldquo;homo_del\u0026rdquo;), heterozygous deletion (\u0026ldquo;het_del\u0026rdquo;), amplification (\u0026ldquo;amp\u0026rdquo;), or no change (\u0026ldquo;norm\u0026rdquo;).\nMutations The CCLE mutations were tidied up, though not much was needed. I cached two data frames: ccle_mutations has all of the mutations, and ccle_mutations_coding has only coding mutations.\nRNA Expression The RNA expression data is described by DepMap as follows:\n RNAseq TPM gene expression data for just protein coding genes using RSEM. Log2 transformed, using a pseudo-count of 1.\n The tall formatted data was cached as ccle_expression.\nKRAS mutants A tibble was made to hold the mutation information KRAS. This included coding mutations and copy number amplifications.\nTODO  Finish munging the new DepMap data.  ","date":1569628800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1569698885,"objectID":"5e30cd0a55835c8ebbde0a91b3c91eaf","permalink":"https://project-notebook-comutation.netlify.com/post/2019-09-28/","publishdate":"2019-09-28T00:00:00Z","relpermalink":"/post/2019-09-28/","section":"post","summary":"I am beginning the migration process from the only comutation directory to this project.\nDownloading DepMap 2019 Q3 release The first step is moving over the raw data into the new data directory. DepMap release 19Q3 data, so the new data sets were downloaded into \u0026ldquo;data/depmap19Q3/\u0026rdquo;\nwget -O Achilles_gene_effect.csv https://ndownloader.figshare.com/files/16757666 wget -O Achilles_gene_dependency.csv https://ndownloader.figshare.com/files/16757660 wget -O Achilles_guide_efficacy.csv https://ndownloader.figshare.com/files/16757669 wget -O Achilles_common_essentials.csv https://ndownloader.figshare.com/files/16757654 wget -O common_essentials.csv https://ndownloader.figshare.com/files/16757714 wget -O nonessentials.csv https://ndownloader.","tags":[],"title":"2019-09-28","type":"post"},{"authors":[],"categories":[],"content":"I have used the \u0026lsquo;ProjectTemplate\u0026rsquo; R package to build the framework for the analysis. I created a lab notebook in reports using the \u0026lsquo;blogdown\u0026rsquo; package which serves the site to the \u0026lsquo;docs/\u0026rsquo; directory.\nThe remote repository is hosted by GitHub at jhrcook/comutation and is private. The lab notebook is hosted by Netlify and is located at project-notebook-comutation.netlify.com. It is open to the public, but is not easily found.\nI have trimmed down the default academic hugo theme to only include the sections About, Posts, and Contact.\n","date":1569283200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1569358927,"objectID":"8dad289a593761b7140ccde512194e26","permalink":"https://project-notebook-comutation.netlify.com/post/new-project-structure/","publishdate":"2019-09-24T00:00:00Z","relpermalink":"/post/new-project-structure/","section":"post","summary":"I have used the \u0026lsquo;ProjectTemplate\u0026rsquo; R package to build the framework for the analysis. I created a lab notebook in reports using the \u0026lsquo;blogdown\u0026rsquo; package which serves the site to the \u0026lsquo;docs/\u0026rsquo; directory.\nThe remote repository is hosted by GitHub at jhrcook/comutation and is private. The lab notebook is hosted by Netlify and is located at project-notebook-comutation.netlify.com. It is open to the public, but is not easily found.\nI have trimmed down the default academic hugo theme to only include the sections About, Posts, and Contact.","tags":[],"title":"2019-09-24 - New project structure","type":"post"},{"authors":["Comutation of KRAS"],"categories":null,"content":" Click the Slides button above to demo Academic\u0026rsquo;s Markdown slides feature.   Supplementary notes can be added here, including code and math.\n","date":1554595200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1554595200,"objectID":"557dc08fd4b672a0c08e0a8cf0c9ff7d","permalink":"https://project-notebook-comutation.netlify.com/publication/preprint/","publishdate":"2017-01-01T00:00:00Z","relpermalink":"/publication/preprint/","section":"publication","summary":"Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum.","tags":["Source Themes"],"title":"An example preprint / working paper","type":"publication"},{"authors":[],"categories":[],"content":" Welcome to Slides Academic\nFeatures  Efficiently write slides in Markdown 3-in-1: Create, Present, and Publish your slides Supports speaker notes Mobile friendly slides  Controls  Next: Right Arrow or Space Previous: Left Arrow Start: Home Finish: End Overview: Esc Speaker notes: S Fullscreen: F Zoom: Alt + Click PDF Export: E  Code Highlighting Inline code: variable\nCode block:\nporridge = \u0026quot;blueberry\u0026quot; if porridge == \u0026quot;blueberry\u0026quot;: print(\u0026quot;Eating...\u0026quot;)  Math In-line math: $x + y = z$\nBlock math:\n$$ f\\left( x \\right) = \\;\\frac{{2\\left( {x + 4} \\right)\\left( {x - 4} \\right)}}{{\\left( {x + 4} \\right)\\left( {x + 1} \\right)}} $$\nFragments Make content appear incrementally\n{{% fragment %}} One {{% /fragment %}} {{% fragment %}} **Two** {{% /fragment %}} {{% fragment %}} Three {{% /fragment %}}  Press Space to play!\nOne  Two  Three \nA fragment can accept two optional parameters:\n class: use a custom style (requires definition in custom CSS) weight: sets the order in which a fragment appears  Speaker Notes Add speaker notes to your presentation\n{{% speaker_note %}} - Only the speaker can read these notes - Press `S` key to view {{% /speaker_note %}}  Press the S key to view the speaker notes!\n Only the speaker can read these notes Press S key to view   Themes  black: Black background, white text, blue links (default) white: White background, black text, blue links league: Gray background, white text, blue links beige: Beige background, dark text, brown links sky: Blue background, thin dark text, blue links   night: Black background, thick white text, orange links serif: Cappuccino background, gray text, brown links simple: White background, black text, blue links solarized: Cream-colored background, dark green text, blue links  Custom Slide Customize the slide style and background\n{{\u0026lt; slide background-image=\u0026quot;/img/boards.jpg\u0026quot; \u0026gt;}} {{\u0026lt; slide background-color=\u0026quot;#0000FF\u0026quot; \u0026gt;}} {{\u0026lt; slide class=\u0026quot;my-style\u0026quot; \u0026gt;}}  Custom CSS Example Let\u0026rsquo;s make headers navy colored.\nCreate assets/css/reveal_custom.css with:\n.reveal section h1, .reveal section h2, .reveal section h3 { color: navy; }  Questions? Ask\nDocumentation\n","date":1549324800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1549324800,"objectID":"0e6de1a61aa83269ff13324f3167c1a9","permalink":"https://project-notebook-comutation.netlify.com/slides/example/","publishdate":"2019-02-05T00:00:00Z","relpermalink":"/slides/example/","section":"slides","summary":"An introduction to using Academic's Slides feature.","tags":[],"title":"Slides","type":"slides"},{"authors":["Comutation of KRAS","Robert Ford"],"categories":null,"content":" Click the Cite button above to demo the feature to enable visitors to import publication metadata into their reference management software.    Click the Slides button above to demo Academic\u0026rsquo;s Markdown slides feature.   Supplementary notes can be added here, including code and math.\n","date":1441065600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1441065600,"objectID":"966884cc0d8ac9e31fab966c4534e973","permalink":"https://project-notebook-comutation.netlify.com/publication/journal-article/","publishdate":"2017-01-01T00:00:00Z","relpermalink":"/publication/journal-article/","section":"publication","summary":"Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum.","tags":["Source Themes"],"title":"An example journal article","type":"publication"},{"authors":["Comutation of KRAS","Robert Ford"],"categories":null,"content":" Click the Cite button above to demo the feature to enable visitors to import publication metadata into their reference management software.    Click the Slides button above to demo Academic\u0026rsquo;s Markdown slides feature.   Supplementary notes can be added here, including code and math.\n","date":1372636800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1372636800,"objectID":"69425fb10d4db090cfbd46854715582c","permalink":"https://project-notebook-comutation.netlify.com/publication/conference-paper/","publishdate":"2017-01-01T00:00:00Z","relpermalink":"/publication/conference-paper/","section":"publication","summary":"Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum.","tags":["Source Themes"],"title":"An example conference paper","type":"publication"}]